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CHAPTER I 
 
INTRODUCTION 
 
In eukaryotic cells, DNA is packed into a highly organized nuclear structure called 
chromatin. The basic unit of chromatin is a nucleosome, which is composed of 146 base 
pairs of DNA wrapped around the histone octamer containing two copies each of 
histones H2A, H2B, H3, and H4 (Fig. 1A). The histone octamer has a core tetramer 
formed by two stably associated H3-H4 dimers, and the H3-H4 tetramer is flanked by 
two separate H2A-H2B dimers (1-3). The formation of histone octamer is mainly 
through the interactions between the hydrophobic globular (histone-fold) domains of 
the four histones. In addition, the histone tail regions protruding from the nucleosome 
core disc are relatively flexible and rich in positively-charged amino acids (arginines 
and lysines), many of which are targeted for enzyme-catalyzed chemical modifications 
(Fig. 1B) (4). 
Given their close contact with DNA, histones can regulate the accessibility of 
underlying genetic information to factors involved in all DNA-templated processes. A 
role for histones in transcription was first shown when incorporation of histone 
inhibited the ability of DNA to serve as the template for in vitro RNA synthesis (5). 
Subsequently, the yeast galactose signaling system was used to show that the depletion 
of histone H4 results in the activation of genes present in the repressive or uninduced 
condition, providing the first in vivo evidence that histones play a general negative role 
in gene expression (6). To gain access to the underlying DNA, cellular processes 
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employ five different mechanisms to remodel the chromatin: modifications of DNA 
(7-10), nucleosome remodeling by ATP-dependent machineries (11), histone exchange 
mediated by chaperones (12), histone variant incorporation, and extensive 
post-translational modifications (PTMs) on histones (13). The concept that the PTMs of 
histones might play an important role in regulating gene expression was initially shown 
by demonstrating that histones are acetylated in vivo and this modification compromised 
the ability of histones to impede transcription (14). Extensive research over the past 40 
years has now revealed that, in addition to acetylation, histones are modified by 
methylation, phosphorylation, ADP-ribosylation, citrullination, ubiquitination and 
sumoylation, and these modifications contribute to the overall complexity of epigenetic 
regulation (Fig.1B) (15).  
Among these PTMs, histone methylation has received particular attention, since it 
can occur in different states based on the number of methyl groups added. Methylation of 
the guanidino group of arginine occurs in two distinct states, either due to the addition of 
a single methyl group (monomethylation) or two methyl groups [dimethylation; wherein 
the methyl groups can be added to a single (asymmetric) or both guanidino (symmetric) 
groups] (Fig. 2A). On the other hand, methylation on the ε-amino group of lysine can be 
present in three distinct states by the addition of either a single methyl group 
(monomethylation, me1), or two methyl groups (dimethylation, me2), or three methyl 
groups (trimethylation, me3) (Fig. 2B). Other than the potential complexity provided by 
the different chemical states, histone methylation can be involved in the activation or 
repression of transcription depending on the position of the modified residue and/or the 
specific protein factors present in different types of cell that recognize the methyl mark 
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Figure 1. Structure and histone modifications of the nucleosome core particle. A, Crystal 
structure of the Xenopus laevis nucleosome core particle. The 146-bp DNA phosphodiester 
backbones are shown in brown and turquoise. The histone protein main chains of H2A (yellow), 
H2B (red), H3 (blue) and H4 (green) are shown. Reproduced from (1) B, Histone modifications 
on the nucleosome core particle. Sites of post-translational modification are indicated by colored 
symbols defined in the key; acK, acetyl lysine; meR, methyl arginine; meK, methyl lysine; PS, 
phosphoryl serine; and uK, ubiquitinated lysine. Adapted from (16). 
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Figure 2. Different methylation states of arginine (A) and lysine (B). 
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(17-18). Methylation of lysine 4 in histone H3 (H3K4), the main focus of my study, is an 
intriguing histone modification mark that displays all the different levels of complexity 
described above. 
 
Histone H3 Lysine 4 (H3K4) Methylation 
 
H3K4 methylation was first found in the trout testes (19). Initial mapping of this 
histone mark in budding yeast suggested that H3K4 methylation occurs in actively 
transcribed regions (20). Further analysis of the genome-wide distribution using 
chromatin immunoprecipitation (ChIP) assays revealed distinct patterns of occupancy for 
the three different H3K4 methylation states at different genomic loci in yeast, plant and 
metazoans (21-25). In budding yeast and Arabidopsis, H3K4 monomethylation 
(H3K4me1) is most abundant at the 3’ ends of active genes (Fig. 3), and dimethylation 
(H3K4me2) spreads throughout the active genes peaking in the middle of the coding 
regions. However, in vertebrate cells, H3K4me2 is localized in discrete zones near active 
genes. Unlike the distribution of H3K4me2, H3K4 trimethylation (H3K4me3) is highly 
associated with the 5’ ends of actively transcribed genes in all examined organisms, 
including yeast, Arabidopsis, fly, chicken, mouse and human (Fig. 3) (21-25), indicating 
an evolutionarily conserved role of trimethylated H3K4 in transcription initiation/ 
elongation in all eukaryotic cells. 
Recent studies have revealed the intriguing complexity of H3K4 methylation 
regarding its functions and/or localization. In budding yeast, H3K4me1 is mainly 
associated with moderately transcribed genes (1-50 mRNA/hr), and also occurs at low  
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Figure 3. Distribution of three different states of H3K4 methylation in active S. cerevisiae 
genes. Adapted from (26). 
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levels in inactive genes (<1 mRNA/hr) (27). However, this histone modification is 
preferentially localized to the repressed genes in Chlamydomonas (28), while in 
mammalian cells, it is considered as an epigenetic mark for enhancers (29-30), suggesting 
that different species might utilize the monomethylated H3K4 for different tasks. The 
H3K4me2 mark has been linked to transcriptional regulation, given its general 
association with active genes. For example, Set3, the defining member of Set3 histone 
deacetylase complex (Set3C), can recognize this histone mark via its plant homeodomain 
(PHD) finger. This Set3-H3K4me2 interaction is critical for the association of Set3C with 
histones and for the co-transcriptional deacetylation of histones at the 5’ end of 
open-reading frames (ORFs) (Fig. 4A) (31). By promoting histone deacetylation to 
prevent the histone eviction in the coding region, H3K4me2 plays a positive role in the 
transcription of Set3 target genes (31-32). In contrast, this histone mark is also important 
for the recruitment of the histone deacetylase Rpd3S complex to the GAL1 gene, 
contributing to the attenuation of GAL1 in the presence of glucose (33). 
The functions of H3K4me3, as compared to those of H3K4me1 and H3K4me2, have 
been explored in more detail and this modification has been implicated to play a role in 
diverse cellular processes occurring on chromatin (Fig. 4B). The structure of chromatin 
can be divided into two states, the loosely-packed euchromatin that is available for active 
transcription and the densely-packed heterochromatin that is transcriptionally silent. The 
H3K4me3, as a hallmark of active chromatin, defines the euchromatin- heterochromatin 
boundary and prevents Sir3 (a silencing protein essential for the formation of 
heterochromatin state) binding to histone H3 (34-35). In the absence of H3K4me3, the 
chromatin-bound Sir3 spreads from the heterochromatin into the neighboring euchromatic 
7 
  
Figure 4. Biological roles of H3K4 methylation. A, Model for two-stage cotranscriptional 
recruitment of Set3 deacetylase complex (Set3C) in yeast. (1) Pol II is phosphorylated on Ser5 of 
the CTD by Kin28 during promoter clearance. (2) Elongating Ser5-phosphorylated Pol II enables 
efficient recruitment of Set3C by direct interaction with Ser5-phosphorylated CTD repeats. 
Subsequently, Set3C is transferred from the phospho-CTD to H3 tails by interaction of H3K4me2 
with the PHD finger in Set3 for histone deacetylation. Adapted from (32). B, Schematic summary 
of the interacting effector proteins and functions of H3K4me3 in eukaryotes.  
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regions (34-35). Therefore, H3K4me3 is critical for proper gene silencing in the 
telomeres and ribosomal DNA locus. Moreover, with the identification of protein 
domains/modules that recognize trimethylated lysine residues (PHD finger, 
chromodomain and tudor domain), progress towards uncovering the biological events 
downstream to H3K4me3 has been expedited. Many factors involved in transcriptional 
activation, including CHD1, BPTF, Yng1 and ING3-5, can recognize H3K4me3, which 
correlates well with the proposal that this histone mark has a role in active transcription 
(36-41). In contrast, H3K4me3 also contributes to gene repression. For instance, ING2 
binds H3K4me3 and recruits Sin3/histone deacetylase (HDAC) complex to repress active 
genes, contributing to the rapid shut-down following DNA damage of genes controlling 
cell proliferation (39). Other than transcriptional regulation, H3K4me3 can recruit RAG2, 
the essential subunit in the RAG recombinase complex required for the V(D)J 
recombination during lymphocyte development (42). RAG2 is recruited onto chromatin 
by virtue of the interaction between its PHD finger and H3K4me3 (43). Given that all 
three methylation states on H3K4 have unique roles in transcription and other 
chromatin-based cellular events, the regulatory mechanisms governing their 
establishment and removal is an important topic in the chromatin field.  
 
The Establishment of H3K4 Methylation 
 
Set1, the only methyltransferase targeting H3K4 in budding yeast, was first identified 
in 1997 as a SET [Su(var)-E(z)-Trithorax] domain-containing protein that is important for 
gene silencing at the telomeres (44). Set1 was demonstrated to be capable of methylating 
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the lysine 4 residue of histone H3 and to be part of a multi-protein complex called 
COMPASS (Complex Proteins Associated with Set1) (45-47). Other than the catalytic 
subunit Set1, the Set1/COMPASS complex also contains seven regulatory subunits: 
Swd1/Cps50/Saf49, Swd2/Cps35/Saf37, Swd3/Cps30/Saf35, Bre2/Cps60, Shg1/Cps15, 
Sdc1/Cps20/Saf19 and Spp1/Cps40/Saf41 (46-48). Swd1 and Swd3 are required for the 
complex integrity and all forms of H3K4 methylation (Fig. 5) (35, 49). Lack of Bre2 or 
Sdc1 results in the complete loss of H3K4me3 with low levels of H3K4me1 and -me2, 
while Spp1 and Shg1 are only required for high levels of H3K4me3 (Fig. 5) (35, 49). In 
higher organisms, there are at least ten SET domain-containing methyltransferases targeting 
the lysine 4 in histone H3, and these enzymes can be divided into two groups based on the 
evolutionary features of their catalytic SET domains. The six Mixed Lineage Leukemia 
(MLL)-family members (MLL1-MLL4, SET1A and SET1B) contain SET domains that are 
related to the SET domain of yeast Set1 and Drosophila Trx, and also associate with other 
regulatory proteins to form complexes similar to the COMPASS complex (Fig. 6) (50-55). 
The other group of methyltransferases, including ASH1, SET7/9, SMYD3 and PRDM9, 
contain Trx-unrelated SET domains (56-60). Interestingly, the functions of these multiple 
enzymes are not redundant, as deletions or truncations in Mll1, Mll2, and Mll3 genes 
resulted in distinguishable phenotypes (61-63). Therefore, it is suggested that the single-cell 
organism like budding yeast can accomplish the methylation task with one single enzyme, 
but the higher organisms need multiple H3K4-targeting methyltransferases to cover the 
regulatory complexity during their development process (64). 
The yeast Set1/COMPASS complex is recruited to active genes by the RNA 
polymerase II (Pol II) elongation machinery (20). Set1 interacts with the Pol II that is  
10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Contributions of the individual COMPASS subunits to Set1-mediated H3K4 
methylation. The levels of H3K4 methylation in the indicated mutant cells were examined by 
Western blotting. From Drs. Zu-Wen Sun and Mahesh B. Chandrasekharan (Unpublished data). 
 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. The components of yeast Set1/COMPASS complex and their homologs in human. 
Adapted from (65). 
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phosphorylated at the serine 5 position on its C-terminal domain (CTD) by the kinase 
Kin28, which mediates the transition between transcriptional initiation and elongation. 
Moreover, two components in the Pol II-associated Paf1 elongation complex, Rtf1 and 
Paf1, also interact with Set1 and are important for the recruitment of Set1/COMPASS 
complex to the actively transcribed ORFs (20, 66). This recruitment mechanism 
correlates well with the general association of H3K4 methylation with active genes in 
yeast. Similar mechanisms for the recruitment of MLL proteins also exist in mammals. 
MLL1 can bind to the Paf1 elongation complex through sequences flanking its CXXC 
domain, and this interaction is required for MLL1 recruitment to target loci (67-68). In 
addition, the specific recruitment of MLL1 also depends on the recognition of 
H3K4me2/me3 by its third PHD finger and the binding of DNA by its CXXC domain (67, 
69). 
The establishment of H3K4 methylation is also regulated by other histone 
modifications in cis and in trans. Asymmetric dimethylation on histone H3 arginine 2 
(H3R2) abrogates the ability of Spp1 to recognize H3, preventing Set1/COMPASS 
complex from trimethylating H3K4 (27). On the other hand, acetylation of histone H3 
lysine 14 (H3K14) may promote trimethylation on H3K4, given that mutation at H3K14 
or loss of Gcn5, the acetyltransferase targeting H3K14, causes reduction in the H3K4me3 
levels (70-71). In addition, the histone H2B lysine K123 mono-ubiquitination (H2Bub1) 
is required for di- and tri-methylation on H3K4, which is the first trans-histone crosstalk 
pathway to be reported (72-73). The H2Bub1 mark can stabilize the nucleosome, 
providing a stable working platform/docking site for Set1/COMPASS complex to 
perform the processive methylation of H3K4 (74). This histone modification is also 
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suggested to modulate H3K4 methylation through regulating the chromatin association 
and ubiquitination of Swd2 (75-76). Independent of H2Bub1, arginine 119 (R119) and 
threonine 122 (T122) in the C-terminal helix of H2B are important for Spp1 binding to 
chromatin and H3K4 methylation (77). Therefore, a current model proposed for the 
trans-histone crosstalk between H2B ubiquitination and H3K4 methylation is that the 
H2Bub1 stabilizes the docking site for Set1/COMPASS complex present on the 
C-terminal helix of H2B, and thereby, contributes to the establishment of H3K4me2 and 
-me3 marks (78). 
 
The Removal of H3K4 Methylation 
 
Histone lysine methylation had been considered to be an irreversible modification 
for the following reasons. First, compared to deacetylation (that involves a simple amide 
bond hydrolysis), removal of a methylation is chemically more difficult, since it requires 
breaking a more stable C-N covalent bond. Second, pulse-chase experiments 
demonstrated that the half-lives of the histone and the methyl marks on it were 
approximately equal, suggesting that the only way to reverse the methylated state of a 
histone is through passive or active histone exchange (79-80). However, the discovery in 
2004 of the first histone demethylase, Lysine-Specific Demethylase 1 (LSD1), has 
converted the conventional concept to a new model that histone methylation is a dynamic 
and truly reversible epigenetic mark (81). LSD1 targets H3K4me1 and -me2, and 
contains an amine oxidase domain that catalyzes the oxidation of the methyl group 
coupled to the reduction of a cofactor flavin adenine dinucleotide (FAD). The oxidized 
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methyl group is then released as formaldehyde, leaving the lysine 4 residue of histone H3 
in the unmodified state (Fig. 7A) (81). Although LSD1 possesses demethylase activity 
toward mono- and di-methylated H3K4, it cannot remove the H3K4me3 mark, owing to 
the requirement of an iminium cation intermediate during the demethylation process (Fig. 
7A). Furthermore, unlike many other organisms including fission yeast, budding yeast 
does not have a homolog of LSD1. Therefore, the demethylation of trimethyl H3K4, and 
all forms of H3K4 methylation in budding yeast, may be conducted through an 
alternative mechanism. 
Following the discovery of LSD1, JHDM1, the founding member of the JmjC 
domain-containing Histone Demethylase (JHDM) family was identified in 2006 (82), and 
other demethylases in the same family were immediately reported independently by 
different groups (83-85). All of the JHDM family members contain a catalytic JmjC 
domain that requires ferrous ion (Fe2+) and α-ketoglutarate (α-KG) as cofactors for its 
demethylase activity. The demethylation mechanism by JHDMs is through the 
oxygenation of the methyl group coupled to the conversion of α-KG to succinate and 
carbon dioxide. The resulting carbinolamine intermediate is chemically unstable and 
undergoes a spontaneous C-N bond cleavage, leaving the methylated lysine in the 
unmodified state and releasing formaldehyde as a byproduct (Fig. 7B) (82). Other than 
the JmjC domain, some JHDMs also have a JmjN domain, which is present N-terminal to 
their JmjC domain. Evidence based on the comparisons of the substrate preferences of 
JmjC and JmjN/JmjC enzymes supports a possibility that JHDMs with both JmjN and 
JmjC domains prefer di- or trimethylated substrates, while enzymes that only contain a 
JmjC domain show demethylase activity toward mono- or dimethylated lysine residues 
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Figure 7. Mechanisms of the demethylation by histone lysine demethylases. A, The 
FAD-dependent amine oxidase mechanism of lysine demethylation by LSD1. B, The Fe2+ and 
α-ketoglutarate-dependent dioxygenase mechanism of lysine demethylation by the JmjC 
domain-containing demethylases. From (86). 
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(87). Therefore, the enzyme responsible for the removal of H3K4me3 mark could be a 
JmjN/JmjC-containing protein. Indeed, in 2007, several groups independently identified 
new demethylases with both a JmjN and JmjC domains, JARID1A-1D, Lid and Jhd2, that 
are capable of erasing the H3K4me3 mark in mammals, fly and budding yeast, 
respectively (88-94). Among these enzymes, JARID1A and 1B are involved in cell cycle 
regulation and linked to tumor progression in mammals, and mutations in JARID1C are 
associated with human X-linked mental retardation, indicating that demethylation on 
H3K4 at the right time and in the right place is critical for proper development and 
differentiation in humans (95-98). Therefore, the homolog of JARID1 family proteins in 
budding yeast, Jhd2, could be a good model for providing important information about 
human diseases. 
 
The H3K4-Specific Demethylase Jhd2 
 
As mentioned above, the yeast Jhd2 was discovered as a H3K4-specific demethylase 
in 2007 (88-90). In the in vitro demethylase activity assay, Jhd2 is capable of removing 
all forms of H3K4 methylation (88, 99). However, this enzyme displayed in vivo 
demethylase activity only towards di- and trimethyl H3K4, since cellular levels of 
H3K4me2 and -me3, but not H3K4me1, were affected following overexpression of Jhd2 
or following deletion of Jhd2 from the cells (88-90, 99-100). The ChIP assay further 
revealed that in the absence of Jhd2, the H3K4 methylation levels at the inducible GAL1 
and SUC2 genes were altered during both the gene activation and attenuation steps (99). 
In addition, consistent with the fact that the H3K4me3 mark is important for proper gene 
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silencing, overexpression of Jhd2 causes a partial relief of telomeric silencing, and the 
loss of this demethylase also delays the establishment of silencing at the mating loci (88, 
101). To date, Jhd2 has not been found to be present as a component of any protein 
complex; instead, size-exclusion chromatography indicated that Jhd2 exists as a 
monomeric protein in cells (88). Supporting this observation, a recent study showed that 
Jhd2 is regulated at the protein levels by the proteasomal degradation following the E3 
ligase Not4-mediated polyubiquitination (100). Despite these advances in the 
understanding of Jhd2 functions, many fundamental questions pertaining to its substrate 
specificity and selectivity, domain contributions, chromatin association and its overall 
regulation remained unanswered. 
 
Research Aims 
 
A unifying theme in this work is the characterization of the function and regulation 
of Jhd2 as the yeast H3K4-specific demethylase. Jhd2 has a role in regulating the levels 
of H3K4 methylation in the inducible GAL1 gene during both the activation and 
repression steps (99). However, whether Jhd2 also functions as a H3K4-demethylase at 
other types of loci on chromatin was unknown. Furthermore, probably owing to its low 
chromatin-bound levels of Jhd2, detection of its locus-specific occupancy by ChIP assay 
was thought to be difficult. Therefore, the direct evidence of the localization of Jhd2 to 
where it functions was lacking. In Chapter III, the chromatin occupancy of Jhd2 at 
different genomic loci detected by a modified ChIP assay that lowers the non-specific 
background signal will be described. In addition, the discoveries that H3K4me3 plays 
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important roles in transcriptional regulation and Jhd2 can modulate the levels of this 
histone mark in the inducible GAL1 gene are extended in this study (64, 99). The 
real-time changes in the Jhd2 and H3K4me3 occupancies in another inducible gene, 
INO1, following a repression-induction-repression treatment course as discussed in 
Chapter III has provided further important information about the dynamics in 
transcriptional regulation. The results support the role of Jhd2 as a demethylase that 
removes the H3K4 methylation mark and is involved in both transcriptional repression 
and activation. This result also reveals the prompt removal of H3K4me3 at INO1 gene in 
response to repressive conditions. Moreover, the differences between the real-time 
changes in H3K4me3 levels in the WT and in the jhd2Δ cells suggest that the H3K4 
methylation can be removed through both active demethylation and passive histone 
replacement. 
As Jhd2 is a newly identified enzyme, very little is known about the mechanisms 
that regulate the demethylation of H3K4 by this protein. Therefore, Chapter IV and V 
will discuss the structural insights into the regulation of Jhd2. Similar to other histone 
demethylases that target trimethylated substrates, Jhd2 contains both a JmjN and JmjC 
domain. However, in contrast to the well-characterized catalytic JmjC domain, the roles 
of JmjN domain in regulating the functions of histone demethylases have remained 
unclear. Previous reports have implied that the JmjN domain is involved in substrate 
selectivity and the maintenance of protein levels (87, 102). In addition, the JmjN domain 
in another histone demethylase, JMJD2A, interacts with the JmjC domain based on its 
crystal structure (102). Sequence alignment revealed that the residues mediating the 
JmjN-JmjC interaction in JMJD2A are conserved in Jhd2 and other JmjN/JmjC 
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demethylases. Therefore, the hypothesis that this inter-domain interaction in Jhd2 is 
involved in the regulation of its demethylase function and protein levels was proposed. 
Evidence supporting this hypothesis and revealing a role of the JmjN domain in the E3 
ligase Not4-mediated proteasomal degradation of Jhd2 will be presented in Chapter IV. 
In addition to the JmjN and the catalytic JmjC domains, Jhd2 also contains another 
conserved motif, namely, the PHD finger. Since PHD fingers present in other proteins 
have been demonstrated to bind trimethylated or unmodified lysine residues in histones 
(91, 103-104), it is conceivable that the PHD finger in Jhd2 may mediate its chromatin 
association by recognizing histones. Chapter V will discuss the roles of PHD finger in 
mediating the Jhd2-chromatin interaction. Data obtained from ChIP assays that 
demonstrate the importance of the PHD finger for the Jhd2 occupancy on chromatin will 
be described. Further, the binding sites on histones for the Jhd2 PHD finger and their 
roles in modulating the demethylase function of Jhd2 in vivo will also be described in 
Chapter V. These structural and functional insights into the Jhd2-catalyzed demethylation 
of H3K4 are beneficial to the understanding of transcriptional regulation and human 
diseases. 
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CHAPTER II 
 
EXPERIMENTAL PROCEDURES 
 
Yeast Strains 
Deletion mutants lacking Jhd2, Set1, Swd1, Sdc1 or Spp1 in YMH171 strain were 
created using PCR products containing the disrupted gene locus and the inserted 
KanMX4 selection module amplified from the genomic DNA template isolated from the 
respective BY4742-based yeast deletion strains (Open Biosystems). Jhd2 was 
genomically tagged with 9 copies of Myc at its C-terminus in YMH171 following PCR 
amplification using pYM6 as the template (105). MSY421, a histone H3/H4 shuffle strain 
(73), was used to mobilize the H3 N-terminal deletion mutant [H3(1-28Δ)]. The 
Flag-H2B and Flag-H2B/set1Δ strains were derived from YZS276 (73). Detailed 
genotypes of the yeast strains described in this study are listed in Table 1. 
  
DNA Constructs 
All the plasmids used in this study are listed in Table 2. For overexpressing the 
jumonji-domain containing proteins, PCR products containing the entire ORFs for RPH1, 
GIS1, ECM5, JHD1 or JHD2, and 500 bp of DNA upstream and downstream of each 
ORF were mobilized into a high copy vector, YEplac112 (106). The C-terminal LexA 
epitope-tagged Jhd2 was created by PCR amplifying the ORF of JHD2 and mobilizing it 
between the ADH1 promoter and a fragment of the LexA DNA binding domain in 
pFBL23 (107). An XhoI-KpnI fragment containing the sequence encoding 9 copies of 
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Table 1.  Saccharomyces cerevisiae strains 
 
Strain Genotype Source 
 
YMH171 Mat α ura3-52 leu2-3,112 his3 trp1Δ (108) 
YZS499 jhd2Δ::KanMX4; derived from YMH171 This study 
YZS500 JHD2-9Myc::klTRP1; derived from YMH171 This study  
YZS512 swd1Δ::KanMX4; derived from YMH171 This study  
YZS513 sdc1Δ::KanMX4; derived from YMH171 This study  
YZS514 spp1Δ::KanMX4; derived from YMH171  This study  
YZS515 set1Δ::KanMX4; derived from YMH171 This study 
MSY421 Mat α hht1-hhf1Δ hht2-hhf2Δ leu2-3,112 ura3-52 trp1-289 his3-Δ1 (73) 
 pMS329 (HHT1-HHF1, URA3, CEN)  
YZS209 pZS136 (HHT2-HHF2, TRP1, CEN); derived from MSY421 This study 
YZS211 pMS358 [hht1-2(1-28Δ)-HHF1, LEU2, CEN]; derived from MYS421 This study  
YZS276 Mat a hta1-htb1Δ::LEU2 hta2-htb2Δ leu2-2,-112 ura3-1 trp1-1 his3-11,-15 (73) 
 ade2-1 can1-100 ssd1 HTA1-Flag-HTB1 (CEN, HIS3) 
YZS522 set1Δ::KanMX4; derived from YZS276  This study 
BY4742 Mat α his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0  Open Biosystems 
D147 not4Δ::KanMX4; derived from BY4742  Open Biosystems 
VU156 pdr5Δ::KanMX4; derived from BY4742 Open Biosystems 
HTA1WT Mat α hta1-htb1Δ hta2-htb2Δ lys2-128δ his3Δ200 ura3-52 (109) 
 pRS313 (HTA1-HTB1, HIS3, CEN) 
HTA1L24A pRS313 [hta1-(L24A)-HTB1, HIS3, CEN]; derived from HTA1WT       (109) 
HTA1T25A pRS313 [hta1-(T25A)-HTB1, HIS3, CEN]; derived from HTA1WT        (109) 
HTA1F26A pRS313 [hta1-(F26A)-HTB1, HIS3, CEN]; derived from HTA1WT         (109) 
HTA1P27A pRS313 [hta1-(P27A)-HTB1, HIS3, CEN]; derived from HTA1WT      (109) 
HTA1R36A pRS313 [hta1-(R36A)-HTB1, HIS3, CEN]; derived from HTA1WT      (109) 
HTA1R37A pRS313 [hta1-(R37A)-HTB1, HIS3, CEN]; derived from HTA1WT      (109) 
L40 Mat a his3Δ200 trp1-901 leu2-3,112 ade2 lys2-801am URA3::(lexAop)8-lacZ (110) 
 LYS2::(lexAop)4-HIS3 
Myc epitope (9Myc) and the CYC1 terminator was obtained following PCR amplification 
and mobilized into pRS314. Subsequently, a 500 bp PCR product containing the JHD2 
promoter was mobilized upstream of the region coding for 9Myc as a SacI-SpeI fragment. 
The entire JHD2 promoter-9Myc-CYC1 terminator module was mobilized as a SacI-KpnI 
fragment into pRS316. The ORF of JHD2 was then PCR amplified and mobilized 
between the JHD2 promoter and the 9Myc-CYC1-terminator sequence in pRS314 or 
pRS316 as a SpeI-XhoI fragment. Point and truncation mutants of Jhd2 were made by 
PCR-based site-directed mutagenesis using pRS314-JHD2-9Myc or pRS316-JHD2-9Myc 
as the template. For overexpression of JHD2 or its mutant derivatives, a fragment 
containing the WT or mutant ORF, the promoter and the CYC1 terminator region was 
excised from the pRS314-based construct and mobilized into the high copy vector, 
pRS426. To obtain purified, recombinant Jhd2 PHD finger or its variants, a sequence 
encoding either the WT PHD finger or its mutant derivatives was amplified by PCR and 
mobilized into a bacterial expression vector, pBG101 (provided by the Vanderbilt 
Structural Biology Core). The plasmids, pCS3+-6Myc and pCS3+-SMCX-6Myc, were 
kindly provided by Ralf Janknecht (111), and the pCS3+-smcx(S451R)-6Myc construct 
was made by PCR-based site-directed mutagenesis. The MBP-JHD2(1-237) construct 
was obtained by PCR amplifying and mobilizing the first 711 bp of DNA in the ORF of 
JHD2 as an NdeI-NcoI fragment into the vector pLM302 (provided by the Vanderbilt 
Structural Biology Core). Similarly, the last 1329 bp of DNA in the ORF of JHD2 was 
PCR amplified and mobilized as a BamHI-EcoRI fragment into the vector pGEX-2T (GE 
Healthcare) for expressing the recombinant GST-tagged amino acids 277-729 of Jhd2 in 
bacteria. HTA1 containing truncations was PCR amplified and mobilized as an 
23 
NdeI-BamHI fragment to replace the wild-type sequence in H2A-pET11a (kindly 
provided by Brad Cairns) (112). All the constructs created using PCR amplification were 
verified by DNA sequencing. 
 
Western Blot Analysis 
To determine changes in Jhd2 levels, whole cell extracts (WCEs) were prepared as 
described (74) and analyzed by Western blotting using antibodies raised against Myc 
epitope (9E10, gift from Ethan Lee) and Pgk1 (22C5, Molecular Probes) at 1:1000 and 
1:5000 dilution, respectively. Crude nuclear extracts were used to examine the levels of 
H3K4 methylation following the cell fractionation procedure described previously (74). 
The following antibodies were purchased from Millipore and used in Western blotting to 
detect H3K4 methylation (dilutions are indicated in parentheses): α-H3K4me1 (1:1000), 
α-H3K4me2 (1:10000) and α-H3K4me3 (1:2500). The histone H3 loading was 
monitored using α-H3 (1:7500, Active Motif). For mammalian WCEs, HeLa cells were 
transfected with pCS3+-6Myc, pCS3+-SMCX-6Myc or pCS3+-smcx(S451R)-6Myc using 
Lipofectamine method. Following a two-day incubation at 37oC, cells were washed prior 
to and after harvesting with ice-cold 1X phosphate-buffered saline (PBS; Sigma), and 
boiled in 1X Laemmli sample buffer (Bio-Rad) for 10 min. After centrifugation (16100 × 
g for 5 min), equal volumes of WCEs were subjected to Western blot analysis using 
α-Myc (1:1000) and α-β-actin (1:10000, Sigma) antibodies. 
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Table 2. Plasmids    
Plasmid Inserted Gene Promoter Vector Source 
pYM6 9Myc & klTRP1 None pWZV87 (105) 
YEplac112 None None YEplac112 (106) 
pFH1 RPH1 RPH1p YEplac112 This Study 
pFH2 GIS1 GIS1p YEplac112 This Study 
pFH3 ECM5 ECM5p YEplac112 This Study 
pFH4 JHD1 JHD1p YEplac112 This Study 
pFH5 JHD2 JHD2p YEplac112 This Study 
pFH6 jhd2 H427A JHD2p YEplac112 This Study 
pFH7 jhd2 Y346A JHD2p YEplac112 This Study 
pFH8 jhd2 H261A JHD2p YEplac112 This Study 
pFH9 jhd2 T359R JHD2p YEplac112 This Study 
p424GPD None GPDp p424GPD (113) 
pFH10 JHD2 GPDp p424GPD This Study 
pFH11 jhd2 H427A GPDp p424GPD This Study 
pFH12 jhd2 Y346A GPDp p424GPD This Study 
pFH13 jhd2 H261A GPDp p424GPD This Study 
pFH14 jhd2 T359R GPDp p424GPD This Study 
pFBL23 LexA ADH1p pN1102 (107) 
pFH15 JHD2-LexA ADH1p pN1102 This Study 
pFH16 9Myc JHD2p pRS314 This Study 
pFH17 JHD2-9Myc JHD2p pRS314 This Study 
pFH18 jhd2 H427A-9Myc JHD2p pRS314 This Study 
pFH19 jhd2 Y346A-9Myc JHD2p pRS314 This Study 
pFH20 jhd2 H261A-9Myc JHD2p pRS314 This Study 
pFH21 jhd2 T359R-9Myc JHD2p pRS314 This Study 
pFH22 jhd2 jmjNΔ-9Myc JHD2p pRS314 This Study 
pFH23 jhd2 NPΔ-9Myc JHD2p pRS314 This Study 
pFH24 jhd2 P/CΔ-9Myc JHD2p pRS314 This Study 
pFH25 jhd2 jmjCΔ-9Myc JHD2p pRS314 This Study 
pFH26 jhd2 CΔ-9Myc JHD2p pRS314 This Study 
pFH27 jhd2 K37E-9Myc JHD2p pRS314 This Study 
pFH28 jhd2 E507K-9Myc JHD2p pRS314 This Study 
pFH29 jhd2 K37E, E507K-9Myc JHD2p pRS314 This Study 
pFH30 jhd2 G34R-9Myc JHD2p pRS314 This Study 
pFH31 jhd2 C1,2A-9Myc JHD2p pRS314 This Study 
pFH32 jhd2 C7,8A-9Myc JHD2p pRS314 This Study 
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Table 2. Plasmids (continued)    
Plasmid Inserted Gene Promoter Vector Source 
pCS3+-6Myc 6Myc CMV pCS3+-6Myc (111) 
pFH33 6Myc-smcx S451R CMV pCS3+-6Myc This Study 
pRS426 None None pRS426 (114) 
pFH34 JHD2-9Myc JHD2p pRS426 This Study 
pFH35 jhd2 jmjNΔ-9Myc JHD2p pRS426 This Study 
pFH36 jhd2 NPΔ-9Myc JHD2p pRS426 This Study 
pFH37 jhd2 CΔ-9Myc JHD2p pRS426 This Study 
pFH38 jhd2 K37E-9Myc JHD2p pRS426 This Study 
pFH39 jhd2 E507K-9Myc JHD2p pRS426 This Study 
pFH40 jhd2 K37E, E507K-9Myc JHD2p pRS426 This Study 
pFH41 jhd2 G34R-9Myc JHD2p pRS426 This Study 
pFH42 jhd2 K37R-9Myc JHD2p pRS426 This Study 
pFH43 jhd2 K37A-9Myc JHD2p pRS426 This Study 
pFH44 jhd2 K37Q-9Myc JHD2p pRS426 This Study 
pFH45 jhd2 C1,2A-9Myc JHD2p pRS426 This Study 
pFH46 jhd2 C7,8A-9Myc JHD2p pRS426 This Study 
pFH47 9Myc JHD2p pRS316 This Study 
pFH48 JHD2-9Myc JHD2p pRS316 This Study 
pFH49 jhd2 H427A-9Myc JHD2p pRS316 This Study 
pFH50 jhd2 jmjNΔ-9Myc JHD2p pRS316 This Study 
pFH51 jhd2 K37E-9Myc JHD2p pRS316 This Study 
pFH52 jhd2 E507K-9Myc JHD2p pRS316 This Study 
pFH53 jhd2 K37E, E507K-9Myc JHD2p pRS316 This Study 
pBG101 6His-GST T7lac pBG101 VUCSB* 
pFH54 6His-GST-JHD2(PHD) T7lac pBG101 This Study 
pFH55 6His-GST-jhd2(PHD C1,2A) T7lac pBG101 This Study 
pFH56 6His-GST-jhd2(PHD C7,8A) T7lac pBG101 This Study 
pBHC80-PHD GST-BHC80(PHD) T7lac pGEX-4T-1 (103) 
pING2-PHD GST-ING2(PHD) T7lac pGEX-4T-1 (103) 
pLM302 HIS-MBP T7lac pLM302 VUCSB* 
pFH57 JHD2(1-237)-MBP T7lac pLM302 This Study 
pGEX-2T GST T7lac pGEX-2T GE Healthcare
pFH58 GST-JHD2(277-729) T7lac pGEX-2T This Study 
H2A-pET11a HTA1 T7lac pET-11a (112) 
pFH59 hta1(2-38)Δ T7lac pET-11a This Study 
pFH60 hta1(25-38)Δ T7lac pET-11a This Study 
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Table 2. Plasmids (continued)    
Plasmid Inserted Gene Promoter Vector Source 
pFH61 hta1(80-98)Δ T7lac pET-11a This Study 
pFH62 hta1(98-132)Δ T7lac pET-11a This Study 
pFH63 hta1(121-132)Δ T7lac pET-11a This Study 
pFH64 hta1(LTFP)Δ T7lac pET-11a This Study 
pFH65 hta1(LLRR)Δ T7lac pET-11a This Study 
 
*Vanderbilt University Center for Structural Biology 
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INO1 Induction and Repression 
WT and jhd2Δ strains were grown in yeast minimal synthetic complete medium 
without inositol (SC-Ino; BIO101) supplemented with 200 μM inositol and 2 mM choline 
(INO1-repression medium) at 30oC overnight (115). The overnight cultures were 
re-inoculated into the INO1-repression medium at 2 × 106 cells/ml and grown at 30oC to 
log phase. Cells (4 × 108) were subjected to formaldehyde cross-linking for ChIP assay 
(INO1 repressed state). The remaining cells were harvested, washed once with SC-Ino 
medium, inoculated at 4 × 106 cells/ml into a fresh SC-Ino medium and grown at 30oC 
for 2 hr to activate INO1 expression. Again, cells (4 × 108) were set aside and subjected 
to formaldehyde cross-linking (INO1 induced state). To assess temporal changes in 
histone modification or Jhd2 occupancy following INO1 repression, cells grown in 
inducing medium were re-inoculated into INO1-repression medium at the following 
initial cell densities and grown at 30oC for the various time periods (indicated within 
parentheses) to obtain ~4 × 108 cells: 7 × 106 cells/ml (20 min), 6 × 106 cells/ml (1 hr), 4 
× 106 cells/ml (2 hr), and 2 × 106 cells/ml (4 hr). Cultures grown to different incubation 
time following INO1 re-repression were then subjected to formaldehyde cross-linking for 
ChIP assay (INO1-re-repression time course). 
 
Chromatin Immunoprecipitation (ChIP) 
Double cross-linking using dimethyl adipimidate (DMA; Sigma) and formaldehyde 
were done essentially as described previously (116) with minor modifications: Following 
incubation in 10 mM DMA, cells were washed and resuspended in 1X PBS containing 
1% formaldehyde, and incubated at room temperature for 45 min with gentle agitation. 
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The cross-linking was stopped by adding 130 mM glycine and incubation for 10 min at 
room temperature. Cells were then washed twice with 1X PBS and harvested to prepare 
soluble chromatin for immunoprecipitating H3, H3K4me3, Jhd2-LexA, and Jhd2-9Myc 
using α-H3, α-H3K4me3, α-LexA (Active Motif) and α-Myc, respectively. ChIP assay 
was performed as described in (117) with modifications in the wash steps. After 
immunoprecipitation, the chromatin-bound agarose beads were washed twice with 1 ml 
of FA140 buffer (50 mM HEPES pH 7.6, 140 mM NaCl, 1 mM EDTA, 1% Triton-X-100, 
0.1% Na Deoxycholate, 1 mM PMSF, 1 μg/ml Pepstatin A, 1 μg/ml Aprotinin and 1 
μg/ml Leupeptin), twice with 1 ml of FA500 buffer (FA140 buffer with 500 mM NaCl), 
and then once with 1 ml of LiCl/NP40 buffer (10 mM Tris.HCl pH 8.0, 250 mM LiCl, 1 
mM EDTA, 0.5% NP-40, 0.5% Na Deoxycholate, 1 mM PMSF, 1 μg/ml Pepstatin A, 1 
μg/ml Aprotinin and 1 μg/ml Leupeptin) followed by elution and purification of bound 
DNA. 
  
PCR Analysis 
The data analysis of quantitative real-time PCR (qPCR) following ChIP was 
performed as described by Chandrasekharan et al. (74) with modifications. Briefly, 
occupancy of H3K4me3 was calculated using the 2-ΔΔCT method (Bio-Rad Real-Time 
PCR applications guide). The occupancy of H3K4me3 in set1Δ strain was used as a 
control to determine non-specific immunoprecipitation and any value obtained for this 
strain was subtracted from the H3K4me3 occupancy values obtained from all other 
strains. Soluble chromatin from yeast strains transformed with plasmid vectors were used 
as negative controls (“no tag”) for ChIP of Jhd2-9Myc and Jhd2-LexA. The 2-ΔCT value 
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obtained for the negative control was subtracted from 2-ΔCT values obtained for test 
samples containing epitope-tagged WT or mutant Jhd2. DNA primers used in this study 
are available upon request. 
  
Cell Fractionation 
Spheroplast preparation and nuclei isolation were performed as previously described 
(74). WCEs were prepared by bead-beating spheroplasts in SUME buffer (1% SDS, 8 M 
Urea, 10 mM MOPS pH 6.8 and 10 mM EDTA, 1 mM PMSF, 1 μg/ml Pepstatin A, 1 
μg/ml Aprotinin and 1 μg/ml Leupeptin) followed by centrifugation (16100 × g for 20 
min). Nuclear extracts were obtained by lysing isolated nuclei in SUME buffer followed 
by sonication and centrifugation (16100 × g for 15 min). For chromatin fractions, isolated 
nuclei were resuspended in a hypotonic solution (3 mM EDTA, 0.2 mM EGTA, 1 mM 
DTT, 1 mM PMSF, 1 μg/ml Pepstatin A, 1 μg/ml Aprotinin and 1 μg/ml Leupeptin) and 
incubated on ice for 30 min. After centrifugation (1700 × g for 5 min), the chromatin 
pellet was washed with the hypotonic solution, and then re-suspended in SUME buffer. 
Following brief sonication, soluble chromatin was obtained by centrifugation at 16100 × 
g for 15 min. Protein concentration of the clarified lysate was measured using Bio-Rad Dc 
Protein Assay Kit following the manufacturer’s instructions, and equal amount of total 
protein was subjected to Western blotting using α-Myc, α-Pgk1 or α-H3 antibodies. 
 
Protein Synthesis Inhibition 
Cycloheximide treatment of yeast was done as described previously (118) with 
minor modifications. Briefly, a 25 ml culture was grown to log phase, and cycloheximide 
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was added to a final concentration of 35 μg/ml to inhibit the translation machinery. 3.5 × 
107 cells were collected at 0, 20, 40 and 60 min after cycloheximide treatment and boiled 
in 100 μl 1X Laemmli sample buffer (Bio-Rad) for 10 min. Following centrifugation 
(16100 × g for 5 min), equal volume of lysates were subjected to Western blot analysis 
using α-Myc or α-Pgk1 antibodies. 
 
Proteasome Inhibition 
A mid-log phase yeast culture (25 ml) was treated either with DMSO or 0.1 mM 
MG132 (the proteasome inhibitor) for 30 min. The effect of proteasomal inhibition on 
Jhd2 or its mutant derivatives was examined in a pdr5Δ strain to allow efficient uptake of 
MG132 (100). Whole cell extracts were prepared and subjected to Western blotting as 
described above. 
 
Tertiary Structure Prediction 
The sequence of PHD domain in Jhd2 was submitted to SWISS-MODEL 
(http://swissmodel.expasy.org/) for structure prediction. The software uses a 
homology-based search and predicts the structure utilizing solved structure(s) as a 
reference. The template used for the structure prediction is the solution structure of the 
PHD finger in SMCY/JARID1D (PDB # 2E6R). 
 
Immobilization of Nucleosomes 
Nuclei from Flag-H2B or Flag-H2B/set1Δ strains were isolated as previously 
described (26), and the DNA content was determined by measuring the OD260 of an 
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aliquot of nuclei diluted in 1N NaOH. Nuclei (equivalent to 660 μg DNA) were 
resuspended in 200 μl EBTX buffer (50 mM HEPES pH 7.6, 0.1 M KCl, 2.5 mM MgCl2, 
0.25% Triton-X-100, 1 mM PMSF, 5 mM NEM, 1 μg/ml Pepstatin A, 1 μg/ml Aprotinin 
and 1 μg/ml Leupeptin). MNase digestion was performed twice by adding 5 μl 0.1 M 
CaCl2 and 500 units MNase (Worthington) to the nuclei suspension followed by 
incubation at room temperature for 10 min, and then 4.5 μl 0.1 M EGTA pH 8.0 was 
added to stop the digestion. After centrifugation (9300 × g for 10 min), supernatants from 
the two digestions were combined. The nucleosome-enriched supernatant was diluted by 
adding an equal volume of EBTX buffer containing 10% glycerol, and subjected to 
α-Flag affinity chromatography (M2, Sigma). After extensive washes with EBTX with 
5% glycerol, the immobilized nucleosomes were stored at 4oC until further use in the in 
vitro nucleosome-binding assay. DNA was isolated from an aliquot of the immobilized 
nucleosomes by phenol-chloroform extraction and ethanol precipitation and resolved in a 
2% agarose gel to examine the size of the nucleosomes bound to α-Flag-conjugated 
agarose beads. 
 
In vitro Nucleosome-Binding Assay 
Recombinant glutathione-S-transferase (GST)-tagged WT and mutant PHD finger 
(amino acid 209-320) of Jhd2 were purified from Escherichia coli using 
glutathione-Sepharose 4B beads following the manufacturer instructions (GE Healthcare). 
GST-tagged PHD finger (2 μg) was incubated with 5 μl nucleosome-containing beads in 
200 μl binding buffer (50 mM Tris.HCl pH 8.0, 150 mM NaCl, 1.5 mM MgCl2, 0.2% 
Triton-X-100, 5% glycerol, 1 mM PMSF, 1 μg/ml Pepstatin A, 1 μg/ml Aprotinin and 1 
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μg/ml Leupeptin) for 2 hr at 4oC. After three washes with the binding buffer, the beads 
were boiled in 1X Laemmli sample buffer (Bio-Rad) for 10 min. Following 
centrifugation (16100 × g for 5 min), the supernatant was subjected to Western blot 
analysis using α-GST (1:20000, GE Healthcare) and α-Flag (M2, 1:5000, Sigma) 
antibodies. 
 
In vitro Pull-Down Assay 
E.coli cells expressing recombinant maltose binding protein (MBP)-tagged 
N-terminal part of Jhd2 [Jhd2(1-237)-MBP], GST-tagged C-terminal part of Jhd2 
[GST-Jhd2(277-729)], or histone H2A mutants were lyzed in lysis buffer (20 mM 
Tris.HCl pH 7.5, 150 mM NaCl, 5% glycerol, 0.01% NP-40, 1 mM DTT, 1 mM PMSF, 1 
μg/ml Pepstatin A, 1 μg/ml Aprotinin and 1 μg/ml Leupeptin) by sonication. Following 
centrifugation (16100 × g for 15 min), the supernatant (lysate) was collected. To examine 
the interaction between the N-terminal and C-terminal parts of Jhd2, the lysate containing 
Jhd2(1-237)-MBP (200 μg total protein) was incubated with the lysate containing 
GST-Jhd2(277-729) (200 μg total protein) in 200 μl lysis buffer for 1 hr at 4oC. For in 
vitro binding of PHD fingers to the H2A mutants, purified GST-tagged PHD finger (5 μg) 
was incubated with the E.coli lysates containing H2A mutants (60 μg total protein) in 200 
μl lysis buffer for 1 hr at 4oC. Incubation was continued for another 1 hr at 4oC after 10 
μl amylose-conjugated agarose beads (New England Biolabs) or glutathione-Sepharose 
4B beads (GE Healthcare) were added to pull down Jhd2(1-237)-MBP or GST-tagged 
PHD finger, respectively. Following 4 washes with wash buffer (lysis buffer containing 
0.1% NP-40), the beads were boiled in 1X Laemmli sample buffer (Bio-Rad) for 10 min. 
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Following centrifugation (16100 × g for 5 min), the supernatant was subjected to Western 
blotting using α-GST (1:20000, GE Healthcare) or α-H2A (1:5000, Active Motif) 
antibody. 
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CHAPTER III 
 
JHD2 FUNCTIONS AS A H3K4-SPECIFIC DEMETHYLASE DURING 
TRANSCRIPTIONAL ACTIVATION AND REPRESSION 
 
Introduction 
 
Since the discovery of histone methylation in 1975, the enzyme that removes this 
histone mark was the “holy grail” of the chromatin field (19). Following the identification 
of the first histone demethylase, LSD1 (81), several JmjC domain-containing proteins 
were immediately reported to also possess the enzymatic activity of demethylating 
histones in human (82, 84-85, 119-120). Given the absence of a homolog of LSD1 in 
budding yeast, the attention for the candidates of yeast histone demethylases have been 
focused on proteins containing the conserved JmjC domain. In 2006, Dr. Mahesh B. 
Chandrasekharan, the postdoctoral fellow in our laboratory, indentified a yeast 
JmjC-containing protein called Jhd2 as the H3K4-specific demethylase (Fig. 8A). 
Subsequently, I started to characterize the function of Jhd2 as a histone demethylase. In 
this chapter, data obtained from in vivo demethylase activity assay and ChIP assay are 
described to demonstrate the role of Jhd2 at different genomic loci in vivo. 
 
Results 
 
Jhd2 is an H3K4 Methylation-Specific Demethylase 
The JmjC domain-containing histone demethylases are evolutionarily highly 
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conserved across many genera (119). There are five JmjC domain-containing proteins 
(Rph1, Gis1, Ecm5, Jhd1 and Jhd2) in budding yeast. Overexpression of JHD2 through a 
high copy, 2μ-based plasmid led to a decrease in H3K4me3 and a modest increase in 
H3K4me1 levels (Fig. 8A, lane 6), and deletion of JHD2 resulted in a slight increase in 
H3K4me3 levels (Fig. 8B). In addition, overexpression of JHD2 in the sdc1Δ strain, 
which contained no detectable H3K4me3 and lower levels of H3K4me1 and -me2 (Fig. 
5), reduced the levels of H3K4me1 and -me2 (Fig. 8C). Moreover, none of the JmjC 
domain-containing proteins exhibited any apparent demethylation of K79-methylated H3 
under the same condition (Fig. 8D). Thus, Jhd2 is an H3K4 methylation-specific 
demethylase that can remove mono-, di- and tri-methylated H3K4 marks in yeast. 
 
Jhd2 Localizes to and Functions at a Constitutively Expressed Gene 
Given the genome-wide distribution of H3K4 methylation (21, 26) and since 
H3K4me3 is closely associated with gene transcription (17, 121), I tested whether Jhd2 
plays a role in controlling this H3 modification during transcription. Towards this end, 
chromatin immunoprecipitation (ChIP) assays were undertaken to assess the occurrence 
and changes, if any, in Jhd2 occupancy and in H3K4me3 levels at the highly expressed 
PMA1 gene. As compared to the WT, deletion of JHD2 (jhd2Δ) or overexpression of 
JHD2-LexA led to a two-fold increase or decrease in H3K4me3 at the promoter and ORF 
regions of PMA1, respectively (Fig. 9A). This result suggests that Jhd2 might be present 
on constitutively and highly expressed genes to maintain their normal H3K4 methylation 
levels. Indeed, ChIP data showed that Jhd2-LexA is present on the promoter and ORF 
regions of the PMA1 gene (Fig. 9B). Interestingly, the distribution pattern of Jhd2-LexA 
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Figure 8. Jhd2 is a H3K4-specific demethylase. (A) Western blot analysis of H3K4 methylation 
levels in crude nuclear extracts obtained from yeast strains which overexpress the indicated 
JmjC-domain-containing proteins. (B) Western blot analysis of H3K4 methylation levels in crude 
nuclear extracts obtained from WT and jhd2Δ strains. (C) Western blot analysis of H3K4 
methylation levels in crude nuclear extracts obtained from the sdc1Δ strain with overexpressed 
JHD2-9Myc. (D) Western blot analysis of H3K79 methylation levels in crude nuclear extracts 
obtained from yeast strains overexpressing the indicated JmjC-domain-containing proteins. 
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across the PMA1 gene is similar to that seen for H3K4me3 (compare Figs. 9A and 9B). 
Similar results were obtained from ChIP assays of HSP104 (Fig. 10A and 10B), which is 
expressed at very low levels under normal conditions (122). Given that H3K4me3 is the 
substrate for Jhd2, the data suggest that Jhd2 might be actively recruited during gene 
transcription to dynamically regulate the H3K4 methylation levels. 
 
Jhd2 Localizes to and Functions at Subtelomeric Regions 
Since proper levels of H3K4me3 are important for gene silencing at telomeres 
(34-35), I hypothesized that Jhd2 may also function as a H3K4 demethylase in the 
subtelomeric regions. Therefore, a ChIP assay was performed to examine the H3K4me3 
levels and Jhd2 occupancies in the regions close to the telomere at the right end of 
chromosome VI in the presence or absence of overexpressed JHD2. Indeed, 
overexpression of JHD2-LexA led to a decrease in H3K4me3 at both the proximal region 
of YFR055W ORF (5’ ORF) and the ORF-free regions (Fig. 11A). Interestingly, the levels 
of Jhd2-LexA at the ORF-free regions were higher as compared to the actively 
transcribed YFR055W (Fig. 11B), while the H3K4me3 levels at the proximal region of 
YFR055W were ~10 fold greater than the ORF-free regions (Fig. 11A). Consistent with 
the previous report that overexpression of JHD2 led to a slight defect in telomeric 
silencing (88), my data suggest that the high levels of Jhd2 may play a role in 
maintaining the low H3K4me3 levels in the ORF-free regions near telomeres. 
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Figure 9. Jhd2 plays a role in regulating the H3K4me3 levels at the PMA1 gene. (A) Changes 
in H3K4me3 levels at the PMA1 locus were analyzed by ChIP assay. Graph depicts the data 
obtained from wild-type control (WT) and a strain lacking Jhd2 (jhd2Δ) in the top panel, and 
from yeast strains overexpressing JHD2 (JHD2 OE) from a high copy plasmid or containing the 
plasmid vector alone in the bottom panel. The H3K4me3 ChIP signals were first normalized to 
total histone H3 ChIP signals (H3K4me3/H3) and then the H3K4me3/H3 values at either the 
promoter, 5’ or 3’ ORF regions in the controls and test samples were normalized to the 
H3K4me3/H3 value obtained for the promoter region in WT (top panel) or vector control (bottom 
panel), which was set as 1. Error bars denote standard error of the mean from two independent 
experiments. (B) Levels of Jhd2-LexA at PMA1 were analyzed by ChIP using α-LexA. LexA 
IP/input values obtained from no-tag control (background) were subtracted from those obtained 
from yeast cells with overexpressed JHD2-LexA, and the resulting differences were defined as 
Jhd2-LexA occupancy. The Jhd2-LexA occupancies at 5’ and 3’ ORF regions were normalized to 
the promoter region, which was arbitrarily set as 1. Error bars denote standard error of the mean 
from two independent experiments. 
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Figure 10. Jhd2 is localized to the HSP104 gene. (A) ChIP analysis of H3K4me3 levels at the 
HSP104 locus in cells expressing N-terminally 9Myc-tagged JHD2. The H3K4me3 ChIP signals 
were first normalized to total histone H3 ChIP signals (H3K4me3/H3) and then the H3K4me3/H3 
values at either the promoter, 5’, mid or 3’ ORF regions in the controls and test samples were 
normalized to the H3K4me3/H3 value obtained for the promoter region in WT (top panel) or 
vector control (bottom panel), which was set as 1. Error bars denote standard error of the mean 
from three independent experiments. (B) Levels of Jhd2-9Myc at HSP104 were analyzed by ChIP 
using α-Myc. Myc IP/input values obtained from no-tag control (background) were subtracted 
from those obtained from yeast cells expressing JHD2-9Myc, and the resulting differences were 
defined as Jhd2-9Myc occupancy. The Jhd2-9Myc occupancies at 5’, mid and 3’ ORF regions 
were normalized to the promoter region, which was arbitrarily set as 1. Error bars denote standard 
error of the mean from three independent experiments. 
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Figure 11. Jhd2 functions as a H3K4 demethylase in the subtelomeric regions. (A) Levels of 
H3K4me3 at four loci (black lines, labeled B-E) in the subtelomeric region close to the right arm 
of chromosome VI (TEL06R) were analyzed by ChIP assay. Graph depicts data obtained from the 
vector alone control or overexpressing JHD2-LexA (JHD2 OE). The H3K4me3 levels at different 
loci are shown as fold change relative to the value obtained for vector alone control at the D locus, 
which is present within an ORF. Error bars denote standard error of the mean from two 
independent experiments. (B) Levels of Jhd2-LexA at TEL06R was analyzed by ChIP using 
α-LexA. LexA IP/input values obtained from no-tag control were subtracted from those obtained 
from strains overexpressing JHD2-LexA, and the resulting differences were defined as Jhd2-LexA 
occupancy. Occupancies of Jhd2-LexA at different loci were normalized to the D region. Error 
bars denote standard error of the mean from two independent experiments. 
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Jhd2 Localizes to and Functions at the Inducible INO1 Gene during both Activation and 
Repression Steps 
Next, to test whether Jhd2 also has a role in the regulation of H3K4 methylation in 
an inducible gene, the kinetics of H3K4me3 levels on the INO1 gene in WT and jhd2Δ 
cells during the activated and repressed states were measured by ChIP assay. Additionally, 
the Jhd2 occupancy at the 5’ ORF region of INO1 was also measured under the same 
conditions. Transcription of INO1, encoding inositol 1-phosphate synthase, is activated or 
repressed by the absence or presence of inositiol-choline in the media, respectively (123). 
As shown in Figure 12A, WT and jhd2Δ cells display similar levels of H3K4me3 in the 
INO1 5’ ORF region during both the initial repressed state and following induction. Upon 
re-repression, the levels of H3K4me3 decrease rapidly in WT cells. However, in the 
absence of JHD2, the reduction of H3K4me3 levels is delayed and it persists for 2 hr 
following re-repression as compared to the WT, where it persists for less than 1 hr. 
Importantly, ChIP data confirm that the Jhd2 occupancy decreases at the 5’ ORF of INO1 
upon induction, but increases immediately upon re-repression (Fig. 12B). Also, the global 
levels of Jhd2 are not affected by the treatments inducing or repressing INO1 (Fig. 12C). 
Taken together, these results show that Jhd2 is required for the rapid removal of the 
H3K4me3 mark upon transcriptional repression of INO1. 
 
Discussion 
 
In vivo H3K4 Demethylase Activity of Jhd2 
Upon overexpression, human JARID1A and JARID1B H3K4 demethylases have the 
ability to target all three states of H3K4 methylation (92, 124-125). While Jhd2 displayed 
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Figure 12. Jhd2 is critical for the prompt removal of H3K4me3 at INO1 upon repression 
following induction. (A) Temporal changes in H3K4me3 following the re-repression of INO1 
measured by ChIP assay. WT and jhd2Δ strains were grown in the inositol-choline containing 
medium for 4 hr to repress INO1 expression (R), then grown in the inositol-free medium for 2 hr 
to induce INO1 expression (In), and then INO1 was repressed again by growing cells in the 
inositol-choline containing medium for the indicated time periods (Re-repression). Cells at 
different time points were subjected to ChIP analysis using α-H3K4me3 and α-H3 antibodies. 
Levels of H3K4me3/H3 at the 5’ ORF of INO1 in WT or the jhd2Δ mutant at different time points 
are shown as fold changes relative to H3K4me3/H3 value obtained at the repressed state for the 
WT, which was set as 1. Error bars denote standard error of the mean from two independent 
experiments. (B) Temporal changes in Jhd2-9Myc occupancy following the re-repression of INO1 
measured by ChIP assay performed essentially as described for (A). Chromatin-bound 
Jhd2-9Myc was immunoprecipitated using α-Myc. Myc IP/input values obtained from the no-tag 
control (background) were subtracted from those obtained for yeast expressing JHD2-9Myc, and 
the resulting difference was defined as Jhd2-9Myc occupancy. The Jhd2-9Myc occupancies at the 
5’ ORF of INO1 at different time points are shown as fold changes relative to the Jhd2-9Myc 
occupancy obtained at the initial repressed state (R), which was set as 1. Error bars denote 
standard error of the mean obtained from two independent experiments. (C) The soluble 
chromatin-containing lysates that were subjected to the ChIP assay in (B) were boiled in 1X 
Laemmli sample buffer to reverse the protein-protein and protein-DNA crosslinks. After brief 
spin, the lysates were subjected to Western blot analysis of Jhd2-9Myc levels using α-Myc. Pgk1 
was used as the loading control. (D) Temporal changes in Rpb1 occupancy following the 
re-repression of INO1 measured by ChIP assay performed essentially as described for (A). 
Chromatin-bound Rpb1 was immunoprecipitated using α-Rpb1. The Rpb1 IP/input value was 
defined as Rpb1 occupancy. The Rpb1 occupancies at the 5’ ORF of INO1 at different time points 
are shown as fold changes relative to the Rpb1 occupancy obtained at the initial repressed state (R) 
for the WT, which was set as 1. 
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activity towards all forms of K4-methylated H3 in vitro (99), overexpression of Jhd2 
resulted in a significant reduction in only H3K4me3 (Fig. 8A) (88, 90). However, when 
the Set1 H3K4 methyltransferase was targeted for rapid degradation, both H3K4me3 and 
H3K4me2 were quickly abolished in a Jhd2-dependent manner (89). These findings 
indicate that Jhd2 can target both H3K4me3 and H3K4me2 in vivo and raise the question 
as to whether it has any intrinsic activity towards H3K4me1 in yeast cells. One 
possibility is that the in vivo activity of Jhd2 towards H3K4me1 in the wild type is 
masked by the conversion of H3K4me2 into H3K4me1. Indeed, my results show that 
overexpression of Jhd2 in sdc1Δ, which lacks H3K4me3, resulted in a reduction of both 
H3K4me2 and H3K4me1 (Fig. 8C, lanes 2). Therefore, results obtained in this chapter 
provide evidence that Jhd2 can demethylate H3K4me1 in vivo and, like its human 
homologs (JARID1A and JARID1B), it targets all forms of K4-methylated H3 for 
demethylation in vivo. 
 
Function of Jhd2 in Transcriptionally Active and Inactive Chromatin Regions 
Several studies have identified Jhd2 as an H3K4 specific demethylase in yeast 
(88-90, 99). However, evidence for its occupancy and distribution on chromatin has been 
lacking. Our ChIP analyses demonstrated for the first time that Jhd2 binds to the 
promoter and coding regions of genes with either high (PMA1) or low (HSP104) 
expression (Figs. 9B and 10B). Moreover, deletion or overexpression of JHD2 resulted in 
a two-fold increase or decrease in H3K4me3 levels at the promoter and ORF regions of 
PMA1, respectively (Fig. 9A). Thus, these results suggest that Jhd2 might be actively 
recruited during gene transcription to dynamically regulate H3K4 methylation levels. 
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Besides active genes, I also showed that Jhd2 functions during the activated state, 
the repressed (un-induced) state and the attenuation phase following repression of the 
inducible INO1 gene. Similar to its association with the constitutively expressed genes, 
Jhd2 also associates with the 5’ ORF region of INO1 during transcriptional induction (Fig. 
12B). However, the levels of Jhd2 at the induced state are 2-fold less as compared to the 
initial repressed state (Fig. 12B). While this decrease in Jhd2 levels might account for the 
4-fold increase in the H3K4me3 levels following induction, H3K4me3 levels were not 
increased in the activated state of INO1 in the absence of Jhd2 (Fig. 12A). Therefore, 
these data suggest that even though Jhd2 is present at INO1 during the activated state, it 
might play only a minor role in regulating the H3K4me3 levels, and the robust increase in 
H3K4me3 levels during INO1 induction is a result of the dominant Set1/COMPASS 
mediated methylation. I found that during re-repression, the levels of H3K4me3 at the 5’ 
ORF of INO1 were decreased rapidly in the WT, but not in jhd2Δ (Fig. 12A). 
Furthermore, my ChIP data also revealed that Jhd2 dissociates from the INO1 5’ ORF 
region upon induction and quickly re-associates with this region upon re-repression (Fig. 
12B). Thus, Jhd2 might play a role in the rapid repression of these induced genes by 
actively removing this H3 modification mark upon re-repression. To the best of my 
knowledge, this is the first demonstration that shows the dynamics of histone 
demethylation and chromatin occupancy of a JmjC-containing protein during activation 
and repression of an inducible gene. 
Similar to INO1, H3K4me3 levels are increased during the GAL1 gene re-repression 
in the absence of Jhd2 (99). However, it is not known whether H3K4 demethylation by 
Jhd2 is sufficient to reestablish the repressed state of GAL1. ChIP analysis did not detect 
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any prolonged occupancy of Rpb1 (the largest subunit of RNA polymerase II) on INO1 in 
jhd2Δ upon reestablishment of its repression (Fig. 12D), suggesting the involvement of 
other mechanism(s) in the re-repression of INO1 and perhaps GAL1. Indeed, deletion of 
both JHD2 and JHD1, an H3K36 specific demethylase, led to a higher GAL1 RNA levels 
during induction than those in the WT or single deletion mutants (99). These findings 
suggest that Jhd2 and Jhd1 (i.e., H3K4 and H3K36 demethylation) might play a 
redundant role in the re-repression of activated genes in yeast. Altogether, results in this 
chapter demonstrate that Jhd2 can dynamically associate with chromatin to modulate 
H3K4 methylation levels on both active (PMA1 and HSP104) and repressed (INO1) 
genes in yeast. These observations are in contrast to the JARID1 family of H3K4 
demethylases from various species, which exert their effects only on repressed genes 
(87). 
Jhd2 is important for maintaining normal telomeric silencing (88). In addition, 
demethylation of H3K4 has been proposed to be a rate-limiting step in the formation of 
silent chromatin at the mating type loci, as loss of JHD2 delayed the establishment of 
silencing in these regions (101). However, there is no evidence that Jhd2 localizes to 
these regions to exert its effect on the formation of silent chromatin. My ChIP data 
showed that when overexpressed, Jhd2 localized and reduced H3K4me3 levels across the 
telomeric regions of the right arm of chromosome VI (TEL06R) (Fig. 11). In keeping 
with the fact that H3K4 is hypomethylated at telomeres and silent mating type loci (126), 
these results suggest that Jhd2 plays an active role in maintaining low levels of H3K4 
methylation required for the formation of silent chromatin in these transcriptionally 
inactive regions. 
46 
CHAPTER IV 
 
THE JMJN-JMJC INTERACTION IN JHD2 IS CRITICAL FOR ITS PROTEIN 
STABILITY MEDIATED BY THE E3 LIGASE NOT4 
 
Introduction 
 
Jhd2 contains three evolutionally conserved domains: JmjN, PHD, and JmjC (Fig. 
13A). As in other JmjC-containing histone demethylases, the JmjC domain in Jhd2 
possesses the enzymatic activity that catalyzes the demethylation reaction (82, 88, 99, 
120). However, the roles of JmjN domain and PHD finger in regulating the demethylase 
function of Jhd2 are unknown. Interestingly, a JmjN domain is never found as a 
stand-alone motif (127). Moreover, many JmjC-containing histone demethylases contain 
both the JmjN and JmjC domains (119, 127-128), suggesting a structural/functional 
linkage between these two domains that contributes to the regulation of demethylase 
function. Indeed, crystal structures have shown that the JmjN domain interacts with the 
JmjC domain in JMJD2A (an H3K9/K36 demethylase) and Rph1 (an H3K36 
demethylase) (102, 129). In addition, the JmjN domain is required for the demethylase 
function of JMJD2 family members (84, 130). Therefore, the JmjN domain in Jhd2 may 
also play a role in mediating the demethylation of H3K4, and it is important to 
understand the mechanism that regulates the function of Jhd2 through its JmjN domain. 
In this chapter, I will describe experimental evidence demonstrating that the interaction 
between the JmjN and JmjC domains in Jhd2 mediates the protein’s structural integrity 
and is critical for its protein stability. I will also present data showing that the E3 ligase 
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Not4 plays a role in monitoring the JmjN-JmjC inter-domain interaction in Jhd2 and 
targets the structurally defective Jhd2 protein for degradation through the proteasome 
pathway. 
 
Results 
 
The Cofactor-binding Residues and the PHD Finger are Important for Jhd2 Activity 
The JmjC domain-containing enzymes require iron (Fe2+) and α-ketoglutarate 
(α-KG) as cofactors for their activities (82). All the highly conserved cofactor-binding 
residues, except Y346 (one of the α-KG binding residues), reside in the JmjC catalytic 
domain of Jhd2 (Fig. 13A). Besides the JmjC domain, Jhd2 also contains a JmjN and a 
PHD finger (Fig. 13A). To investigate the importance of these different domains for Jhd2 
function, I created point mutations in the conserved residues that bind α-KG (Y346A) or 
Fe2+ (H427A), or reside in the PHD finger (H261A). As compared to the WT, 
overexpression of these jhd2 mutant alleles showed that while jhd2(H261A) and 
jhd2(Y346A) caused only a modest decrease in H3K4me3 levels, jhd2(H427A) had no 
apparent reduction (Fig. 13B). Thus, binding to cofactors and maintaining an intact PHD 
finger are important for the function of Jhd2 in vivo. 
  
  
T359R, a Substitution Mutation Corresponding to a Human SMCX Mutation Linked to 
Mental Retardation, Affects both the Demethylase Function and Global Protein Level of 
Jhd2 
Mutations in SMCX/JARID1C, a human homolog of Jhd2, have been associated with 
X-linked mental retardation (XLMR) (96, 131-132). Patients carrying one of the well-  
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Figure 13. Mutations in the conserved regions of Jhd2 can affect its activity and overall 
protein levels. (A) Schematic representation and domain locations of Jhd2. The three conserved 
domains, JmjN, PHD finger and JmjC, are shown. Dark gray circles, residues that bind to the 
cofactor ferrous ion (Fe2+); white circles, residues binding to the cofactor α-ketoglutarate (α-KG); 
light gray and black circles, a conserved residue (H261) in the PHD finger and a conserved 
residue (T359) corresponding to a human mental retardation-linked mutation site, respectively. 
Alignment of the Jhd2 sequence flanking the T359 residue to the SMCX sequence flanking one of 
the sites mutated in X-linked mental retardation (S451) is also shown. (B) Western blot analysis 
of H3K4 methylation levels in crude nuclear extracts from cells overexpressing the WT JHD2 or 
its mutants. (C) Western blot analysis of the levels of Jhd2-9Myc or its mutant derivatives in the 
whole cell extracts (WCEs). The level of Pgk1 serves as a control for total protein loading. (D) 
Whole cell extracts were prepared from HeLa cells expressing 6Myc-tagged SMCX or the mutant 
(smcx-S451R), and protein levels were examined using α-Myc. The level of β-actin serves as a 
control for total protein loading. 
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characterized XLMR mutations in SMCX (S451R) developed mental retardation and also 
showed mild deformities in the tongue and fingers (131). However, the molecular 
consequence(s) of this mutation was not known. The S451 residue resides in a region that 
is highly conserved from yeast to human (Fig. 13A, bottom panel) (119). To investigate 
the effect of S451R on SMCX function in vivo, I generated a corresponding mutation 
T359R in Jhd2. Unlike the overexpression of the WT JHD2, overexpression of 
jhd2(T359R) did not reduce H3K4me3 levels (Fig. 13B, lane 6), suggesting that this 
mutation might abrogate the enzymatic activity and create a null allele of Jhd2. 
Interestingly, the T359R mutation also resulted in a severe reduction in the steady-state 
protein levels as compared to the WT JHD2 and other jhd2 alleles (H427A, H261A or 
Y346A) (Fig. 13C). This result suggests that the T359 residue might be important for 
regulating the protein stability of Jhd2. Next, I examined whether the residue S451 in 
SMCX is important for maintaining protein stability in human cells. To this end, 
SMCX-6Myc and smcx(S451R)-6Myc were ectopically expressed in HeLa cells. Western 
analyses revealed that similar to Jhd2(T359R), the total protein levels of 
smcx(S451R)-6Myc were lower than those of the WT SMCX-6Myc (Fig. 13D), 
suggesting a conserved role for residues T359 and S451 in maintaining the protein 
stabilities of Jhd2 and SMCX, respectively. Importantly, this decrease in protein levels of 
smcx(S451R) likely accounts for the observed defects in patients harboring this mutation 
(131). 
 
The Structural Integrity of Jhd2 is Important for its Protein Stability 
Although the JmjN domain is highly conserved, it does not exist in all the JmjC 
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domain-containing histone demethylases (119). For example, JmjN domain is absent in 
the H3K36 demethylases, such as human JHDM1 (JHDM1A and JHDM1B) and yeast 
Jhd1. To determine the contribution of this domain to Jhd2 function, I created a deletion 
derivative lacking the JmjN domain [Jhd2(JmjNΔ)] and examined the effect of this 
truncation on the ability of Jhd2 to remove H3K4 methylation (Fig. 14A). Unlike the WT, 
overexpression of jhd2(JmjNΔ) did not reduce H3K4 methylation (Fig. 14B), indicating 
that the JmjN domain is essential for Jhd2 function. Intriguingly, protein levels of the 
overexpressed jhd2(JmjNΔ) appeared reduced compared to the WT (Fig. 14B). Indeed, a 
drastic reduction in steady-state levels of Jhd2(JmjNΔ) is evident when the proteins are 
expressed from the endogenous JHD2 promoter using a low copy (CEN-based) plasmid 
(Fig. 14C). This result suggests that the structural integrity of Jhd2 is important for 
maintaining its whole-cell protein levels. In contrast, levels of Jhd2(JmjNΔ) in the nuclear 
extracts were higher than the WT (Fig. 14C). Given the increase in nuclear Jhd2(JmjNΔ) 
levels, it is conceivable that the lack of H3K4 demethylation in this mutant (Fig. 14B) is 
due to the truncation and not due to reduced global protein levels (Fig. 14C, top panel). 
Taken together, these novel findings put forth a possibility that the overall protein 
stability and nuclear localization of Jhd2 might be regulated by its protein structure. 
Previous studies have revealed the presence of two SMCX splice variants in human 
cells and both proteins catalyze in vivo H3K4 demethylation. Whereas, the longer form of 
SMCX is predominantly a nuclear protein (91, 97, 133), its shorter splice variant (lacking 
the C-terminal 120 amino acids) is present at very low levels in the nucleus (111). Taken 
together, these studies and my findings suggest that controlling the nuclear localization of 
SMCX and Jhd2 might be a mode to regulate their H3K4 demethylation on chromatin. 
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Figure 14. The JmjN domain in Jhd2 is important for its global protein level and subcellular 
localization. (A) Schematic representation of the Jhd2 and its truncation mutant. The JmjN, PHD 
and JmjC domains are represented as shown in Figure 13A. (B) Crude nuclear extracts were 
prepared from jhd2Δ strain containing vector alone or overexpressing the WT or mutant JHD2. 
The levels of H3K4 methylation were examined by Western blotting. (C) The levels of Jhd2 and 
Jhd2(JmjNΔ) in the WCEs (top panel) and nuclear extracts (bottom panel) were examined by 
Western blotting. Pgk1 and H3 were used as loading controls in the WCEs and nuclear extracts, 
respectively. 
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Therefore, I examined the levels of Jhd2 and its mutant derivatives in addition to 
Jhd2(JmjNΔ) within the nucleus (Fig. 15A). As expected, all deletions of Jhd2 abolished its 
function as a demethylase (Figs. 14 B and 15B). Moreover, except for the C-terminal 
deletion mutant [Jhd2(CΔ)], all the mutants showed decreased steady-state protein levels 
and increased nuclear protein levels similar to Jhd2(JmjNΔ) (Fig. 15C). These results show 
that any change in the structural integrity of the region encompassing JmjN and JmjC 
domains of Jhd2 that abrogates its enzymatic function will lead to a decrease in its global 
protein levels, but increase its nuclear protein levels. 
Next, I tested whether these changes in Jhd2 levels in the whole-cell and nuclear 
extracts are due to the loss of its enzymatic activity. To this end, the whole-cell and nuclear 
levels of the catalytically-dead allele, Jhd2(H427A), were examined (Fig. 13B). As shown 
in Figure 17C, both the global and nuclear levels of Jhd2(H427A) are similar to the WT. 
Thus, the loss of enzymatic activity alone does not alter protein levels of Jhd2 and strongly 
implicates the protein structural perturbations induced by the deletions as the primary cause 
for the observed changes in its global and nuclear protein levels. Given that the human 
XLMR mutation-mimetic change in Jhd2, T359R, also showed a drastic reduction in steady 
state protein levels (Figs. 13C and 16) and loss of demethylase function (Fig. 13B) similar 
to that seen for the deletion mutants (Figs. 14 and 15), I assessed the protein levels of this 
point mutant in the nucleus. Indeed, similar to the deletion derivatives, the nuclear protein 
levels of Jhd2(T359R) are increased as compared to the WT (Fig. 16), suggesting that this 
point mutation alone is sufficient to perturb the structural integrity of Jhd2 and alter its 
global and nuclear protein levels. Collectively, these findings suggest that the protein 
stability of Jhd2 might be regulated by its structure and not by its enzymatic activity. 
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Figure 15. The global protein level and subcellular localization of Jhd2 are sensitive to its 
structural integrity. (A) Schematic representation of the Jhd2 and its truncation mutants. The 
JmjN, PHD and JmjC domains are represented as shown in Figure 13A. (B) Crude nuclear 
extracts were prepared from jhd2Δ strain containing vector alone or overexpressing the WT or 
mutant JHD2. The levels of H3K4 methylation were examined by Western blotting. (C) Western 
blot analysis of the levels of WT Jhd2 and its truncation mutants in the WCEs (top panel) and 
nuclear extracts (bottom panel). 
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Figure 16. Western blot analysis of the levels of Jhd2 and Jhd2(T359R) in the WCEs and 
nuclear extracts. 
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To test whether the protein stability of Jhd2 is compromised by mutations, I 
examined the global levels of WT Jhd2 and its mutants following inhibition of protein 
synthesis using cycloheximide. As shown in Figure 17A, deletion of JmjN domain causes 
rapid degradation of Jhd2. Compared to WT Jhd2 levels, Jhd2(JmjNΔ) is barely 
detectable at 20 min after cycloheximide treatment and it is completely absent at 40 min 
following the translational arrest. Recently, the E3 ligase Not4-mediated polyubiquitination 
followed by proteasomal degradation was shown to modulate the steady-state levels of 
Jhd2 (100). Therefore, I tested whether the compromised protein stability of Jhd2(JmjNΔ) 
is due to a high protein turnover mediated by the proteasome. Supporting this possibility, 
proteasomal inhibition using MG132 resulted in increased steady state levels of 
Jhd2(JmjNΔ) (Fig. 17B). I further tested whether Not4 is involved in this 
proteasome-mediated degradation of Jhd2(JmjNΔ). Indeed, the steady state levels of 
Jhd2(JmjNΔ) are restored nearly to WT levels in the not4Δ strain (Fig. 17C), and this 
mutant protein is highly stabilized in cells lacking Not4 (Fig. 17D). These findings 
suggest a protein structure-monitoring role for Not4 in maintaining Jhd2 levels. 
Additionally, the nuclear protein levels of Jhd2(JmjNΔ) were increased in not4Δ as 
compared to both WT Jhd2 and Jhd2(H427A) (Fig. 17C). Taken together, these findings 
reveal that the structural integrity of Jhd2 is a crucial determinant for maintaining its 
protein stability mediated by Not4. 
 
The Interaction between JmjN and JmjC Domains is Important for Jhd2 Function 
Crystal structure of the catalytic-core domain of human JMJD2A, an H3K9me3- and 
H3K36me3-specific demethylase, has revealed a physical interaction between the two 
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Figure 17. Loss of the JmjN domain in Jhd2 causes protein instability mediated by the E3 
ligase Not4 and the proteasome. (A) Cells containing WT Jhd2 or Jhd2(JmjNΔ) mutant were 
treated with 35 μg/ml cycloheximide (CHX) for the indicated periods of time to terminate protein 
synthesis. Equal amount of WCEs were subjected to Western blotting using α-Myc and α-Pgk1 
antibodies. (B) Western blot analysis of the levels of WT Jhd2 and its mutants in WCEs obtained 
from cells treated with DMSO (vehicle) or with MG132. (C) The levels of WT Jhd2 and its 
mutants in WCEs and nuclear extracts obtained from control (WT) or not4Δ strains were detected 
using α-Myc. (D) Western blot analysis of the levels of WT Jhd2 and Jhd2(JmjNΔ) mutant in 
WCEs obtained from control (WT) or not4Δ strains treated with cycloheximide (CHX) for the 
indicated time. 
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antiparallel β strands in its JmjN and JmjC domains (Fig. 18A) (102). The residues 
constituting each β strand of the JmjN and JmjC domains are highly conserved among the 
demethylases containing both these domains (119), implicating an important role for the 
inter-domain interactions in regulating demethylation. Indeed, it has been proposed that this 
JmjN-JmjC interaction might cause a conformational change in the JMJD2A catalytic-core 
to activate its enzymatic function (102). Although differing in their substrate specificity, the 
strong sequence similarity between the two β strands in JmjN and JmjC of JMJD2A and 
Jhd2 (Fig. 19A) suggests that an inter-domain interaction might also occur in Jhd2 to 
regulate its function. To test this possibility in vitro, I performed MBP pull-down assay 
using Jhd2(1-237)-MBP (encompassing JmjN) and GST-Jhd2(277-729) (encompassing 
JmjC) (Fig. 18B). Indeed, the JmjN-containing N-terminal part of Jhd2 interacted with its 
JmjC-containing C-terminal part in vitro (Fig. 18C). Next, to test my hypothesis that the 
JmjN-JmjC interaction in Jhd2 is important for its function in vivo, I mutated the conserved 
residues in the β strands in JmjN and JmjC domains of Jhd2 (Fig. 19A) and assessed their 
effects on its enzymatic function. Unlike the WT, overexpression of jhd2(G34R), 
jhd2(K37E) and jhd2(E507K) did not reduce H3K4me3 levels (Fig. 19B), indicating that 
these conserved residues are important for Jhd2 function. Moreover, similar to jhd2(T359R) 
null mutant, the global protein levels are reduced and nuclear protein levels are increased in 
these jhd2 mutants (Fig. 19C), suggesting that these mutations might also perturb the 
structural integrity and elicit the proteasome-mediated protein degradation response (100). 
Indeed, the protein stabilities of Jhd2(K37E) and Jhd2(E507K) are severely compromised 
(Fig. 20A), and MG132- mediated proteasomal inhibition resulted in increased steady state 
levels of these two Jhd2 mutants (Fig. 20B). 
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Figure 18. The N- and C-terminal parts in Jhd2 interact with each other. (A) The crystal 
structure of JMJD2A (PDB # 2GP5). The JmjN (green) and JmjC (blue) domains interact with 
each other through one β-strand in JmjN domain (yellow) and another one in JmjC domain 
(purple). The two cofactors, ferrous ion (red) and α-ketoglutarate (brown), are represented by the 
space-filling model. (B) Schematic representation of Jhd2(1-237)-MBP and GST-Jhd2(277-729).  
The JmjN (N; green), PHD (P; pink) and JmjC (C; blue) domains are shown. (C) In vitro MBP 
pull-down assay. The MBP- or Jhd2(1-237)-MBP-containing E.coli lysates (200 μg total protein) 
were incubated with GST- or GST-Jhd2(277-729)-containing E.coli lysates (200 μg total protein) 
and were pull-downed by the amylose-conjugated beads. After extensive washing, the 
MBP/Jhd2(1-237)-MBP-bound GST/GST-Jhd2(277-729) were eluted in sample buffer. E.coli 
lysates containing GST or GST-Jhd2(277-729) (1%, Input) and eluates (40%) were subjected to 
Western blot analysis using α-GST. An aliquot of the eluate (10%) was also used as a control to 
show the equal loading of MBP or Jhd2(1-237)-MBP, as detected using SimplyBlue stain. 
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Figure 19. Residues that might mediate the JmjN-JmjC interaction are critical for the 
global protein levels and subcellular localization of Jhd2. (A) Top panel: the crystal structure 
of JmjN and JmjC domains of JMJD2A are represented as shown in Figure 18A. The two residues, 
lysine in JmjN domain (orange) and glutamate in JmjC domain (pink), involved in ionic 
interaction are represented by the space-filling model. Bottom panel: the protein sequence 
alignment of residues involved in the JmjN-JmjC interaction of JMJD2A and Jhd2. + denotes 
similar residues. (B) Western blot analysis of H3K4 methylation levels in the crude nuclear 
extracts prepared from jhd2Δ containing high copy plasmid alone or overexpressing WT JHD2 or 
its mutants. (C) WCEs (top panel) and nuclear extracts (bottom panel) were obtained from jhd2Δ 
strain containing low copy plasmids containing WT JHD2 or mutant variants and subjected to 
Western blotting using α-Myc, α-Pgk1, and α-H3 antibodies. 
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The close proximity between K37 in JmjN domain and E507 in JmjC domain suggests a 
charge-based interaction might occur between these two residues (Fig. 19A). Therefore, I 
created a charge-switching double mutation (K37E, E507K) and tested whether it can 
restore Jhd2 function as compared to the single site mutations (K37E or E507K). 
Overexpression of jhd2(K37E/E507K) did not reduce H3K4 methylation (Fig. 19B), 
indicating a disruption of the enzyme function due to the introduced mutations. However, 
its whole-cell protein levels were modestly increased as compared to jhd2(K37E) or 
jhd2(E507K) (Figs. 19C and 20B). This result suggests that a charge-based interaction 
might occur between K37 and E507. However, the charged-side chains in K37E and 
E507K might not be present in a correct orientation for efficient inter-domain interaction, 
leading to the loss of enzyme function. Alternatively, maintaining a positively charged 
residue at amino acid position 37 in JmjN domain and/or a negative one at position 507 in 
JmjC domain might be important for the structural integrity and for inter-domain 
interactions. Supporting this possibility, only the overexpression of a mutant jhd2 
containing the charge-conserved substitution mutation (K37R), but not jhd2(K37A) and 
jhd2(K37Q), retained demethylation function and reduced H3K4me3 levels similar to 
overexpression of the WT (Fig. 21A). 
To assess how mutations of the K37 residue in Jhd2 affect its in vivo demethylase 
function toward H3K4me2 and -me1, I overexpressed the WT JHD2 and its mutant 
alleles (K37R, K37A and K37Q) in a yeast strain lacking H3K4me3 due to the deletion of 
SDC1, a Set1-COMPASS subunit (134). Overexpression of the WT JHD2 (Fig. 21B, lane 
2) and jhd2(K37R), but not jhd2(K37A) (Fig. 21B, lanes 3-4), reduced H3K4me2 and 
H3K4me1 in sdc1Δ as compared to the control (vector alone). Therefore, the K37 
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Figure 20. Loss of the JmjN-JmjC inter-domain interaction in Jhd2 causes protein 
instability mediated by the proteasome. (A) Western blot analysis of the levels of WT Jhd2 and 
its mutants in WCEs obtained from cells treated with cycloheximide (CHX) for the indicated 
periods of time. (B) Western blot analysis of the levels of WT Jhd2 and its mutants in WCEs 
obtained from cells treated with DMSO (vehicle) or with MG132. 
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Figure 21. The positive charge at amino acid position 37 in JmjN domain is important for 
the demethylase function of Jhd2. (A, B) Western blot analysis of H3K4 methylation levels in 
the crude nuclear extracts prepared from jhd2Δ (A) or sdc1Δ (B) cells overexpressing WT JHD2 
or its mutant derivatives. 
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residue in Jhd2 is also critical for the demethylation of H3K4me1 and -me2 catalyzed by 
Jhd2. Interestingly, overexpression of the acetylation-mimetic jhd2(K37Q) allele, which 
cannot demethylate H3K4me3 (Fig. 21A, lane 5), reduced only H3K4me2 levels (Fig. 
21B, lane 5). Given that the K→Q substitution in jhd2(K37Q) is an acetylation-mimetic 
mutation, I hypothesized that the JmjN-JmjC interaction is modulated by acetylation of 
K37 within the JmjN domain. To test this hypothesis, an N-terminally Flag-tagged Jhd2 
was purified and subjected to mass spectrometry to determine whether the K37 residue in 
Jhd2 was acetylated. The Flag-Jhd2 and Flag-Jhd2(K37R) mutant were also purified and 
subjected to Western blot analysis using an α-acetyled-lysine antibody to examine the 
K37 acetylation. Neither of the two methods provided evidence showing that Jhd2 is 
acetylated at the K37 residue (data not shown). However, the possibility that the K37 
acetylation in Jhd2 only occurs upon some specific cellular conditions cannot be ruled 
out. Nevertheless, my results suggest that the inter-domain interaction between JmjN and 
JmjC domains through their two β strands might play a role in modulating the 
demethylation function of Jhd2 towards different methylation states of H3K4.  
 
Discussion 
 
The Role of JmjN Domain in Mediating Jhd2 Demethylase Function 
Crystal structure of the catalytic-core domain of human JMJD2A (an H3K9me3- and 
H3K36me3-specific demethylase) has shown extensive contacts between the two 
antiparallel β strands in its JmjN and JmjC domains (Figs. 18A and 19A) (102). Given 
the strong sequence similarity between the β strands in JmjN and JmjC of JMJD2A and 
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Jhd2 (Fig. 19A), my results suggest that this JmjN-JmjC interaction might also occur in 
Jhd2 and importantly, this inter-domain interaction is required for Jhd2 activity in vivo 
(Figs. 19B and 21A). Comparison of the substrate preferences of all known 
JmjC-containing histone demethylases have revealed that enzymes with only a JmjC 
domain prefer mono- and di-methylated substrates, whereas those containing both JmjN 
and JmjC domains (JmjN/JmjC) demethylate either di- and tri-methylated lysines or all 
forms of substrates (87). Therefore, the difference in substrate specificity, especially 
tri-methylated lysines targeted by the JmjN/JmjC-containing demethylases, is likely to be 
imparted by the JmjN domain through its interaction with JmjC. Indeed, I found that 
different amino acid substitutions at the conserved K37 in the JmjN domain exerted 
differential affects on Jhd2 function. While the charge-conserved mutation [jhd2(K37R)] 
maintained normal Jhd2 activity in vivo, jhd2(K37A) totally abolished demethylation 
(Figs. 21A-B). In contrast, jhd2(K37Q) demethylated only H3K4me2, but not H3K4me3 
and H3K4me1 (Figs. 21A-B). These results suggest that the inter-domain interaction 
between the two β strands of JmjN and JmjC might play a role in modulating the 
substrate specificity of Jhd2. 
 
Regulation of Not4-mediated Protein Degradation of Jhd2 
The results from this study showed that except for the C-terminal deletion mutant 
[Jhd2(CΔ)], all the Jhd2 truncation mutants showed decreased steady-state protein levels 
(Fig. 15C). In contrast, it has been shown that deletion of the PHD finger alone had no 
apparent effect on Jhd2 protein levels (100). These findings suggest that any change in 
the structural integrity of the region encompassing JmjN and JmjC, but not the PHD 
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finger, domains of Jhd2 can lead to a decrease in its global protein levels. In keeping with 
this hypothesis, I found that point mutations in the conserved antiparallel β strands 
involved in JmjN-JmjC inter-domain interaction (Fig. 19C), but not those in the 
conserved C4HC3 zinc-binding motif of the PHD finger (Fig. 22B), also caused a 
decrease in Jhd2 protein levels. Collectively, these results indicate that any perturbation 
of the proper inter-domain interaction between the JmjN and JmjC domains can adversely 
affect the steady state levels of Jhd2.  
The mechanism by which Not4 recognizes and targets Jhd2 for degradation is not 
fully understood. Importantly, I showed that the Jhd2(JmjNΔ) protein is stabilized and its 
global levels were restored nearly to the WT levels in the not4Δ strain (Figs. 17C-D), 
suggesting a protein structure monitoring role for Not4 in controlling Jhd2 levels. 
However, the Jhd2(JmjNΔ) mutant is apparently less stable than the WT Jhd2 even in the 
absence of Not4 (Fig. 17D), indicating that other parallel pathway(s) may also play a role 
in the structural quality control of Jhd2. Collectively, based on my findings, I propose 
that Not4 might modulate the protein levels of Jhd2 by monitoring its structural integrity, 
especially the proper interaction between the JmjN and JmjC domains. 
Jhd2 localizes to both cytoplasm and nucleus (135). The differential subcellular 
localization of the two SMCX (human homolog of Jhd2) splice variants suggests that 
controlling the nuclear localization of SMCX and Jhd2 might be a way to regulate their 
H3K4 demethylation on chromatin (91, 97, 111, 133). Intriguingly, while the deletion and 
point mutations of Jhd2 resulted in a decrease in steady state levels, their levels in the 
nucleus were all higher than the WT Jhd2 (Figs. 15C, 16 and 19C). Furthermore, in the 
not4Δ mutant, the global Jhd2(JmjNΔ) levels were increased and are equivalent to the 
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WT, but its nuclear levels were dramatically increased and exceed the WT levels (Fig. 
17C). These results reveal a link between the structural integrity and subcellular 
localization of Jhd2. The observation in this study is reminiscent to that seen for the yeast 
transcription factor Msn2, which upon activation by certain stress conditions (glucose 
exhaustion, chronic stress or low protein kinase A activity) accumulates in the nucleus 
(136) and an increase in its protein degradation under these conditions also results in a 
reduction in its overall whole-cell protein levels. Therefore, I propose that through an 
unknown mechanism(s) (e.g., increased nuclear import or decreased nuclear export), the 
Jhd2 mutants accumulate in the nucleus. Subsequently, due to the improper JmjN-JmjC 
inter-domain interaction, the altered-forms Jhd2 are then targeted for rapid degradation by 
Not4 leading to lower whole-cell protein levels than the WT Jhd2. 
Finally, like Jhd2(P/CΔ) (Fig. 15C), Jhd2(T359R) also displayed lower steady state, 
but higher nuclear, levels than Jhd2 (Figs. 13C and 16). These results indicate that 
residues, including T359, located between the PHD finger and JmjC domain are 
important for the structural integrity of Jhd2. Interestingly, the global levels of human 
smcx(S451R), a mutation corresponding to Jhd2(T359R), were lower than the WT 
SMCX/JARID1C (Fig. 13D), suggesting a conserved role for residues T359 and S451 in 
maintaining the protein stabilities of Jhd2 and SMCX, respectively. Since human Not4 
can also polyubiquitinate SMCX in vitro (100), my findings suggest the presence of a 
conserved pathway involving Not4 that modulates the protein stability of both yeast Jhd2 
and human SMCX. In addition, deletion of the JmjN domain from JMJD2A also resulted 
in a reduction in its global protein levels (102, 137). The intriguing similarity in the 
phenotypes of Jhd2 and JMJD2A mutants due to a loss of JmjN domain further implies 
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that the protein stability of JARID and JMJD2 family members may be regulated by a 
conserved mechanism. 
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CHAPTER V 
 
THE PHD FINGER IN JHD2 IS IMPORTANT FOR ITS CHROMATIN 
ASSOCIATION BY INTERACTING WITH HISTONE H2A 
 
Introduction 
 
How the chromatin association of Jhd2 is regulated is an important question for 
further understanding its function in transcriptional regulation. Intriguingly, Jhd2 contains 
a plant homeodomain (PHD) finger between the JmjN and JmjC domains (Fig. 13A). The 
PHD finger was first identified in an Arabidopsis protein, HTA3.1 (138), and this 
conserved domain is present in many proteins involved in modulating chromatin structure 
and dynamics. In 2006, the PHD fingers in ING2 and BPTF were demonstrated to 
recognize trimethylated H3K4 and mediate the chromatin association of these two 
proteins (37, 39, 41). Subsequently, other PHD fingers were also reported to bind either 
trimethylated H3K4, unmodified H3K4, trimethylated H3K9, or acetylated H3/H4 (43, 
91, 103, 139). These findings suggest that the PHD finger in Jhd2 may play a role in 
mediating its chromatin association and therefore, contribute to the removal of the H3K4 
methylation mark. In this chapter, I will show the experimental results demonstrating that 
the demethylase function and normal chromatin association of Jhd2 is indeed dependent 
on its PHD finger. Evidence supporting the possibility that the N-terminal region in H2A 
is critical for the chromatin-Jhd2 PHD finger interaction will also be described. In 
summary, the findings uncovered in this chapter provide important insights into the 
regulation of H3K4 demethylation by Jhd2. 
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Results 
 
The PHD Finger is Required for the Demethylation Activity and Chromatin Association 
of Jhd2  
The PHD finger between JmjN and JmjC domains of the JARID1 family of H3K4 
demethylases contains a conserved C4HC3 zinc-binding motif (Fig. 13A) (119). Based on 
the solution structure of the PHD finger in human SMCY (JARID1D, an H3K4 
demethylase; PDB # 2E6R), the three cysteine residues (C1, C2 and C6) together with the 
histidine residue (H5) present in Jhd2 PHD finger can be predicted to form the first 
zinc-finger, while the remaining cysteine residues (C3, C4, C7 and C8) form the second 
one (Fig. 22A). To determine the role for these two zinc-coordinating sites in Jhd2 
function, I disrupted the PHD finger by creating two double mutants, jhd2(C1, 2A) and 
jhd2(C7, 8A). Whereas, overexpression of jhd2(C1, 2A) resulted in a reduction of 
H3K4me3, overexpression of jhd2(C7, 8A) had no apparent effect (Fig 22B). Moreover, 
only the overexpression of jhd2(C1, 2A) in sdc1Δ caused a reduction in H3K4me2, but 
not jhd2(C7, 8A) (Fig. 22C). Collectively, these results show that disruption of the second 
zinc-binding site within the PHD finger abrogates the demethylase function and therefore, 
it is more critical for Jhd2 activity towards H3K4me2 and H3K4me3 than the first one. 
Many, if not all, PHD-containing proteins associate with chromatin through the direct 
interaction between their PHD finger and the histones (140-141). Therefore, it is 
conceivable that the loss of demethylation in the PHD finger mutants may be due to a poor 
association of Jhd2 with chromatin. To test this possibility, in vitro nucleosome binding 
assays were performed. To obtain mononucleosomes, nuclei isolated from the WT yeast 
strain containing Flag-H2B were digested extensively with micrococcal nuclease 
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Figure 22. The two zinc fingers in PHD domain are important for the function of Jhd2 as an 
H3K4 demethylase. (A) A speculative structure for the PHD finger of Jhd2 as predicted by 
SWISS-MODEL, a knowledge-based protein-modeling algorithm (http://swissmodel.expasy.org/). 
The two zinc-coordinating sites each composed of four residues (cysteine or histidine) are shown. 
(B, C) Western blot analysis of H3K4 methylation levels in the crude nuclear extracts prepared 
from jhd2Δ (B) or sdc1Δ (C) strains overexpressing WT JHD2 or PHD finger mutant variants. 
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(MNase) followed by immunoprecipitation using α-Flag agarose beads. Agarose gel 
electrophoresis of DNA isolated from the immobilized nucleosomes is ~150 bp in length, 
confirming the presence of mainly mononucleosomes (Fig. 23A). Subsequently, equal 
amounts of immobilized mononucleosomes were used to pull-down the purified, 
recombinant GST-tagged PHD finger of Jhd2 (GST-PHD) or its mutants [GST-PHD(C1, 
2A) and GST-PHD(C7, 8A)]. As shown in Figure 23B, GST-PHD, but not GST alone, 
was able to interact with the immobilized nucleosome. However, compared to GST-PHD, 
both the PHD finger mutants [GST-PHD(C1, 2A) or GST-PHD(C7, 8A)] showed reduced 
binding to the nucleosome (Fig. 23B, lanes 7-8). This reduced chromatin binding of the 
PHD finger mutants agrees well with their debilitated demethylase activities as compared 
to the WT (Figs. 22B-C). However, GST-PHD(C7, 8A) showed better nucleosome 
binding than GST-PHD(C1, 2A) (Fig. 23B, lanes 7-8), even though only the jhd2(C7, 8A) 
PHD finger mutation abrogated the in vivo demethylation activity of Jhd2 (Figs. 22B-C). 
Therefore, to further confirm whether the PHD finger in Jhd2 is important for its in vivo 
chromatin association, ChIP assays were performed to assess the occupancy of 
C-terminally 9Myc epitope-tagged Jhd2 and its PHD finger mutants [jhd2(C1, 2A) and 
jhd2(C7, 8A)] on the HSP104 gene. Consistent with their effects on Jhd2 demethylation 
function, the occupancy of Jhd2(C7, 8A) was more profoundly reduced on the promoter 
and ORF regions of HSP104 than Jhd2(C1, 2A) as compared to the WT (Fig. 24). 
Collectively, my findings showed that the structural integrity of the PHD finger, 
especially the second zinc-coordinating site, is important for the association of Jhd2 with 
chromatin in addition to its contributions to the H3K4 demethylase function. 
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Figure 23. The Jhd2 PHD finger interacts with mononucleosomes in vitro. (A) Nuclei isolated 
from WT or set1Δ strains containing Flag-H2B were digested using MNase to solubilize 
chromatin. The released soluble chromatin was immobilized onto α-Flag (M2)-conjugated 
agarose beads. The DNA fragments isolated from immobilized chromatin resolved in 2% agarose 
gel show the presence of predominantly mononucleosomes (~146 bp). Marker, 100 bp DNA 
ladder. (B) In vitro mononucleosome binding assay. The immobilized mononucleosomes obtained 
from the WT were incubated with recombinant GST-tagged WT or mutant PHD fingers of Jhd2 
(2 μg). After extensive washing, the mononucleosome-bound recombinant proteins were eluted in 
sample buffer. Recombinant proteins (40 ng, Input) and eluates (40%) were subjected to Western 
blot analysis using α-GST. An aliquot of the eluate (10%) was also used as a control to show the 
equal loading of immobilized mononucleosomes, as detected using α-Flag. Asterisk, denotes the 
light chain of mouse IgG. 
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Figure 24. ChIP analysis of the levels of WT Jhd2 or PHD finger mutant variants at HSP104. 
The levels of Jhd2 or its mutant variants at the promoter (P), 5’, middle (M) and 3’ ORF regions 
were normalized to the level of WT Jhd2 at the promoter region, which was set as 1. Error bars 
denote standard error of the mean from three independent experiments. 
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Chromatin Association of Jhd2 is Independent of H3K4 Methylation and the H3 
N-terminal Tail Region  
Recently, PHD fingers have emerged as a class of specialized modules that bind to 
the trimethylated-lysine residues on histones, such as H3K4, -K9 or -K36 (140, 142). 
Since H3K4me3 is the substrate of Jhd2, it is conceivable that the PHD finger in Jhd2 
may mediate its chromatin association by recognizing trimethyl H3K4. To test this 
possibility, ChIP assays were performed to determine the Jhd2 occupancy on the HSP104 
gene in an spp1Δ strain that has reduced levels of H3K4me3 (Fig. 25). Surprisingly, no 
change in Jhd2 occupancy was evident in spp1Δ when compared to the WT, suggesting 
that the association of Jhd2 with chromatin is independent of H3K4me3.  
To further confirm that H3K4me3 is not a prerequisite for the chromatin binding of 
Jhd2, chromatin fractionation analysis was performed to assess the global levels of Jhd2 
on chromatin in the WT or mutants lacking subunits of the Set1-COMPASS complex. To 
this end, nuclei isolated from the WT and mutants were gently lysed using a hypotonic 
solution to obtain chromatin as described (5-6). To detect the chromatin-bound 
Jhd2-9Myc expressed from its endogenous promoter, equal amounts of chromatin from 
each strain were subjected to Western analyses using α-Myc. Initially, the levels of 
Jhd2-9Myc on chromatin were assessed in spp1Δ and sdc1Δ mutants, wherein H3K4me3 
levels were either reduced or completely abolished, respectively. As shown in Figure 26A, 
the chromatin-bound Jhd2-9Myc levels in spp1Δ and sdc1Δ were similar to those from 
the WT. This result confirmed that the chromatin-association of Jhd2 is independent of 
H3K4me3. Additionally, compared to the WT, no change in chromatin-bound Jhd2-9Myc 
levels was seen in set1Δ and swd1Δ mutants that completely lack H3K4 methylation (Fig. 
26A). This finding suggests that the chromatin binding of Jhd2 is independent of not only  
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Figure 25. ChIP analysis of the levels of H3K4me3 and Jhd2 occupancy at HSP104 in WT 
and spp1Δ cells. Top panel, levels of H3K4me3 at the promoter (P), 5’, middle (M) and 3’ ORF 
regions in HSP104 were analyzed by ChIP assay. Graph depicts data obtained from the WT or 
spp1Δ cells. Bottom panel, levels of Jhd2-9Myc at HSP104 was analyzed by ChIP using α-Myc. 
Myc IP/input values obtained from no-tag control were subtracted from those obtained from 
strains expressing JHD2-9Myc, and the resulting differences were defined as Jhd2-9Myc 
occupancy. Fold changes in H3K4me3 levels or Jhd2-9Myc occupancy at various regions of 
HSP104 are shown relative to their respective levels at the promoter region in WT, which was set 
as 1. Error bars denote standard error of the mean from three independent experiments. 
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H3K4me3, but also all forms of H3K4 methylation. 
To determine whether the chromatin-association of Jhd2 mediated by its PHD finger 
is indeed independent of H3K4 methylation, in vitro nucleosome binding assays were 
performed as described above (Figs. 23A-B). To this end, I used mononucleosomes 
isolated from the set1Δ strain that lacks H3K4 methylation (Fig. 23A) and assessed the 
ability of Jhd2 PHD finger or its mutant derivatives to bind to the immobilized 
nucleosomes. As shown in Figure 26B, GST-PHD and its mutant derivatives bind 
mononucleosomes from set1Δ strain similar to their binding to mononucleosomes 
isolated from the WT strain containing H3K4 methylation (Fig. 23B). This finding 
confirms the need for an intact PHD finger to interact with chromatin and importantly, 
suggests that the in vitro interaction between the Jhd2 PHD finger and mononucleosomes 
is not dependent on H3K4 methylation. Moreover, the pull-down assay showed that the 
Jhd2 PHD finger interacted with the purified recombinant, unmodified H3 in vitro (Fig. 
26C). In the presence of ethidium bromide (EtBr), which can disrupt protein-DNA 
interaction (143), the Jhd2 PHD finger still binds to H3 (Fig. 26C, lanes 3-4), indicating 
that their association is not mediated by DNA and thus, the Jhd2 PHD finger may 
physically and directly interact with unmodified H3. 
Consistent with the in vitro interaction between the Jhd2 PHD finger and 
unmodified H3, several PHD fingers, including the N-terminal PHD finger of human 
JARID1A H3K4 demethylase, have recently been shown to bind to nonmethylated-K4 
containing H3 peptides comprised of amino acids 1-20 (103, 144-146). Interestingly, 
chromatin fractionation analysis in this study showed that Jhd2 associated with chromatin 
in vivo even in the absence of the H3 N-terminal tail region lacking amino acids 1-28 
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Figure 26. The Jhd2-chromatin association is independent of H3K4 methylation. (A) 
Western blot analysis of the Jhd2 levels in chromatin extracts (top panel) and WCEs (bottom 
panel) obtained from WT or strains lacking Set1-COMPASS complex components, Set1, Swd1, 
Sdc1 or Spp1. Asterisk, denotes a α-Myc cross-reacting protein. (B) In vitro mononucleosome 
binding assay was performed as described in Figure 23B using the immobilized 
mononucleosomes isolated from set1Δ. Asterisk, denotes the light chain of mouse IgG. (C) In 
vitro GST pull-down assay. The recombinant GST-tagged Jhd2 PHD finger (5 μg) was incubated 
with recombinant H3 (0.25 μg) in the absence or presence of ethidium bromide (EtBr) as 
indicated and pull-downed by the glutathione-conjugated beads. After extensive washing, the 
Jhd2 PHD finger-bound H3 were eluted in sample buffer. Recombinant H3 (12.5 ng, Input) and 
eluates (40%) were subjected to Western blot analysis using α-H3. The top part of the blot was 
stained with Ponseau S to show the equal loading of GST and GST-tagged Jhd2 PHD finger. (D) 
Western blot analysis of the Jhd2 levels in chromatin extracts (top panels) and WCEs (bottom 
panels) prepared from WT or H3(1-28Δ) strains. 
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[H3(1-28Δ)] (Fig. 26D). Therefore, my finding suggests that Jhd2 might be binding to 
some other region(s) of unmodified H3. 
 
The N-terminal Region of Histone H2A is Important for its Interaction with the Jhd2 
PHD Finger in vitro 
To date, the known recognition targets for PHD fingers are restricted to H3 and H4 
(37, 39, 41, 43, 91, 103, 139). However, it is possible that the Jhd2 PHD finger can also 
interact with other histones. To test this possibility, the in vitro pull-down assay was 
performed using purified recombinant GST-tagged PHD fingers and E. coli lysates 
containing either recombinant H2A or H2B. Interestingly, the GST-tagged Jhd2 PHD finger 
can pull-down H2A, but not H2B (Figs. 27A-B, lane 3). In contrast, the BHC80 PHD 
finger, which binds to unmodified H3K4 (103), did not show any detectable interaction 
with H2A or H2B (Figs. 27A-B, lane 4), while the ING2 PHD finger, which binds to 
trimethylated H3K4 (39), interacts with both H2A and H2B (Figs 27A-B, lane 5). These 
results suggest that only a subset of PHD fingers has the ability to recognize H2A and/or 
H2B, and the PHD finger in Jhd2 selectively binds to H2A. To identify which regions in 
H2A are important for its interaction with the Jhd2 PHD finger, mutant derivatives of H2A 
were generated (Fig. 28A), and the association of Jhd2 PHD finger with these H2A mutants 
was examined by in vitro pull-down assay. As shown in Fig. 28B, deletion of amino acids 
2-38 or 25-38 from H2A resulted in the partial disruption of the H2A-JHD2 PHD finger 
interaction, suggesting that the α1 helix in H2A (Fig. 28A) is important for this 
protein-protein interaction. However, less than 50% of the residues in the α1 helix of H2A 
are accessible when H2A is incorporated in a nucleosome (Fig. 29A). Therefore, the 
residues (L24 to P27, R36 and R37) that are exposed to outside of the nucleosome may  
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Figure 27. The Jhd2 PHD finger interacts with H2A in vitro. The recombinant GST-tagged 
PHD fingers (5 μg) were incubated with the E.coli lysates containing recombinant H2A (A) or 
H2B (B), and were pull-downed by the glutathione-conjugated beads. After extensive washing, 
the PHD finger-bound H2A (A) or H2B (B) were eluted in sample buffer. E.coli lysates (1%, 
Input) and eluates (40%) were subjected to Western blot analysis using α-H2A (A) or α-H2B (B). 
The top part of the blots was stained with Ponseau S to show the equal loading of GST and 
GST-tagged PHD fingers. 
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Figure 28. The α1 helix in H2A is important for the Jhd2 PHD finger-H2A interaction. (A) 
Left panel: Schematic representation of the H2A and its truncation mutants. The αN, α1, α2, α3 
and αC helixes are shown. Right panel: Crystal structure of H2A (PDB # 1ID3) with the αN, α1, 
α2, α3 and αC helixes represented in the same color as shown in the left panel. The amino acids 
99-120 and 121-132 are shown in yellow and brown, respectively. (B) In vitro GST pull-down 
assay was performed as described in Figure 27 using the E.coli lysates containing H2A or its 
truncation mutants. 
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Figure 29. The amino acids 24-27 and 34-37 in H2A are important for the Jhd2 PHD 
finger-H2A interaction. (A) Crystal structure of yeast nucleosome (PDB # 1ID3). The two 
patches in the H2A α1 helix that are exposed to the outside of nucleosome are shown in blue 
(amino acids 24-27; LTPF) and yellow (amino acids 36-37; RR), and other residues in this helix 
are shown in red. H2A, DNA and other histones are shown in pink, green and grey, respectively. 
(B) In vitro GST pull-down assay was performed as described in Figure 27 using the E.coli 
lysates containing H2A or its truncation mutants. 
 
82 
play a role in mediating the interaction between H2A and the Jhd2 PHD finger. To test 
this hypothesis, the H2A mutants lacking amino acids 24-27 (LTFPΔ) or 34-37 (LLRRΔ) 
were generated and subjected to the in vitro pull-down assay as described above. Indeed, 
both the H2A(LTFPΔ) and H2A(LLRRΔ) mutants showed reduced binding to the Jhd2 
PHD finger as compared to the WT H2A (Fig 29B). Thus, my data suggest that the amino 
acids 24-27 and 34-37 in H2A are important for the Jhd2 PHD finger to interact with 
H2A in vitro. 
 
The F26 Residue in H2A is Critical for the Chromatin Association of Jhd2 Mediated by 
its PHD Finger 
Next, I tested whether those H2A residues are also critical for the demethylase 
function of Jhd2 in vivo. As shown in Fig. 30, overexpression of JHD2 in the H2A(L24A) 
or H2A(F26A) mutant had no apparent effect on the H3K4me3 levels, indicating that 
these two residues, L24 and F26, in H2A are required for the demethylation of H3K4 by 
Jhd2. In addition, the protein levels of Jhd2 in the H2A(L24A) mutant were lower than 
those in the WT H2A cells (Fig. 30), suggesting that mutation of the L24 residue in H2A 
may compromise the expression or protein stability of Jhd2. Interestingly, the Jhd2 levels 
were not affected in H2A(F26A) (Fig. 30). Given that an intact PHD finger is critical for 
the normal chromatin association of Jhd2 (Fig. 24), I hypothesized that the F26A 
mutation in H2A may disrupt the chromatin association of Jhd2 mediated by its PHD 
finger. To test this hypothesis, ChIP assays were performed to assess the occupancy of 
Jhd2-9Myc on the HSP104 and PMA1 genes in cells containing WT H2A or the 
H2A(F26A) mutant. Indeed, the occupancy of Jhd2 was reduced in the promoter and 
5’ORF regions of HSP104 in the H2A(F26A) mutant as compared to that in the WT cells  
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Figure 30. The L24 and F26 residues in H2A are important for Jhd2 function. Western blot 
analysis of H3K4 methylation levels in the crude nuclear extracts prepared from WT or H2A 
mutants overexpressing JHD2. 
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Figure 31. The H2A L26 residue is critical for normal chromatin association of Jhd2. ChIP 
analysis of the levels of Jhd2 in the WT or H2A(F26A) cells at HSP104 (A) and PMA1 (B). The 
levels of Jhd2 in the WT or H2A(F26A) cells at the promoter (P), 5’, middle (M) and 3’ ORF 
regions were normalized to the level of Jhd2 in the WT cells at the promoter region, which was 
set as 1. Error bars denote standard error of the mean from two independent experiments. 
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(Fig. 31A). Moreover, the occupancies of Jhd2 in the promoter and ORF regions of 
PMA1 were also decreased in the H2A(F26A) mutant (Fig. 31B). Therefore, the results 
showed that the F26 residue in H2A is critical for Jhd2 binding to chromatin, probably 
through its PHD finger, and my findings reveal a novel docking-site on the nucleosome 
for Jhd2 to function as the H3K4 demethylase. 
 
Discussion 
 
Controlling the Chromatin Association of Jhd2 
Exactly how the H3K4 demethylases belonging to the JARID1 family interact with 
chromatin is not fully understood. Although not present in Jhd2, all the JARID1 H3K4 
demethylases from higher eukaryotes harbor an ARID/BRIGHT DNA-binding domain, 
which is required for their demethylation activities (93, 124-125, 147). However, it is not 
known whether the ARID/BRIGHT domain is essential for their association with 
chromatin. In this study, I showed that the PHD finger is important for Jhd2 to associate 
with chromatin and for its in vivo activity (Figs. 22-24). The PHD finger in most 
JmjC-domain-containing demethylases and transcription factors binds to either H3 
containing methylated lysine (K4, K9, K27, K36) or unmodified H3 N-terminal tail 
region (140-141). However, while the PHD finger is important for Jhd2 chromatin 
association in vivo (Fig. 24), it binds to mononucleosomes independent of H3K4 
methylation, and to unmodified recombinant H3 in vitro (Figs. 23B and 26B-C). 
Moreover, the in vivo association of Jhd2 with chromatin is not dependent on H3K4 
methylation (Figs. 26A and D) and is independent of the first twenty-eight amino acids of 
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H3 (Fig. 26C). Collectively, this study put forth a novel possibility that through its PHD 
finger, Jhd2 might associate with chromatin via binding to H3 outside of its N-terminal 
tail region. 
Other than H3, I demonstrated that the Jhd2 PHD finger also binds to H2A in vitro 
(Fig. 28A). Furthermore, the F26 residue in H2A is critical for Jhd2 to associate with 
chromatin and function as a H3K4 demethylase (Figs. 31-32). These results suggest that 
this H2A residue is critical for the chromatin association of Jhd2 mediated by its PHD 
finger. Interestingly, the N-terminus of H2A (amino acids 4-20) is important for high 
levels of H2B K123 mono-ubiquitination and the establishment of H3K4me3 (148). 
Given the close proximity of F26 residue to the N-terminus of H2A, it is possible that the 
N-terminal region of H2A may have a dual-property role in regulating the establishment 
and removal of H3K4 methylation through H2B-H3 trans-histone crosstalk and Jhd2, 
respectively. In summary, this study identifies a novel recognition target, H2A, for the 
PHD finger family, and my findings also suggest the N-terminal region of H2A as a novel 
docking-site for Jhd2 to associate with chromatin. 
 
Linking the Chromatin Association and Demethylase Function of Jhd2 
Jhd2 is 85 kD in size, which is comparable to the size of a histone octamer (110 kD). 
Therefore, when bound to H2A, Jhd2 may essentially cover the whole histone octamer. 
The amino acids 1-37 in H3 did not show a fixed conformation in the crystal structure of 
a yeast nucleosome (PDB # 1ID3), suggesting that the H3 N-terminal tail is highly 
flexible. This structural flexibility of the H3 N-terminal tail might enable the efficient 
presentation of methylated H3K4 to the JmjC domain of histone-bound Jhd2. Therefore, 
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it is conceivable that Jhd2 may bind to H2A via its PHD finger and remove the H3K4 
methylation mark in the same nucleosome using its JmjC domain. Alternatively, Jhd2 
may associate with one nucleosome and demethylate other nucleosomes that are in close 
proximity. 
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CHAPTER VI 
 
SUMMARY AND FUTURE DIRECTIONS 
 
Summary 
 
As a recently identified and highly conserved JmjC-containing protein, Jhd2 was 
poorly understood regarding its function and regulation before this study. Prior studies 
have shown that Jhd2 actively removes the H3K4me2 and -me3 marks in vivo, and it is 
polyubiquitinated by the E3 ligase Not4 and degraded by the proteasome (Fig. 32, left 
panel) (88-90, 100). In this dissertation study, three major findings on the function and 
regulation of Jhd2 were made: First, I have demonstrated that Jhd2 has in vivo 
demethylase activity toward all three forms of H3K4 methylation (Fig. 32, right panel, 1). 
Furthermore, I found that Jhd2 binds to and regulates H3K4 methylation on both active 
and repressed genes, and in the sub-telomeric regions. Second, I demonstrated that the 
inter-domain interaction between JmjN and JmjC in Jhd2 is critical for its subcellular 
localization and for the protein stability modulated by the E3 ligase Not4 (Fig. 32, right 
panel, 2). Perturbation of this JmjN-JmjC interaction in Jhd2 led to its polyubiquitination 
by Not4 and subsequently, degradation by proteasome. Third, I have shown that the PHD 
finger of Jhd2 is important for its chromatin association by binding to H2A (Fig. 32, right 
panel, 3). I have also identified H2A F26 as an important residue for Jhd2-chromatin 
association. In summary, this dissertation study has revealed novel insights into the 
function and regulation of Jhd2 as an H3K4 demethylase. 
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Figure 32. Model for the regulation of Jhd2. Left panel, Jhd2 has been shown to demethylate 
H3K4me2 and -me3 in vivo, and to be polyubiquitinated by the E3 ligase Not4 and degraded by 
proteasome in the previous studies (88-90, 99-100). Right panel, the three major findings in this 
dissertation study are shown: (1) Jhd2 demethylates H3K4me1, -me2 and -me3 in vivo. (2) The 
E3 ligase Not4 plays a role in monitoring the JmjN-JmjC interaction in Jhd2. (3) The PHD finger 
in Jhd2 mediates its chromatin association by binding to H2A, and the H2A F26 residue is 
important for this Jhd2-chromatin association. 
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Future Directions 
 
What is the Role of Jhd2 in Transcriptional Regulation? 
Jhd2 plays a role in removing H3K4me3, the histone mark for active transcription, 
during gene repression at both GAL1 and INO1 (Figs. 12A-B) (99, 149). However, in the 
absence of Jhd2, the dissociation of Pol II from the INO1 gene upon transcriptional 
repression following induction is not affected (Fig. 12D). In addition, the GAL1 transcript 
levels remain unaffected in the cells lacking either Jhd2 or Jhd1 (an H3K36 demethylase) 
alone, but are up-regulated in the absence of both Jhd2 and Jhd1 (99). These results 
suggest that Jhd2 and Jhd1 may play redundant repressive roles in regulating gene 
expression. Intriguingly, expressing LexA DNA-binding domain-tagged Jhd2 in cells 
harboring the (lexAop)8-LacZ reporter leads to the activation of LacZ expression (Fig. 33), 
suggesting that Jhd2 can also positively regulate transcription when recruited to DNA. 
Taken together, it is possible that Jhd2 can play either a positive or a negative role in the 
transcriptional regulation in a context-dependent manner. Therefore, genome-wide 
analysis of genes up- or down-regulated in the absence of Jhd2 by RNA microarray may 
provide important clues for the role of Jhd2 in regulating transcription. Also, although 
Jhd2 does not form a stable protein complex in vivo (88), it is possible that Jhd2 may 
transiently associate with other proteins to exert its transcriptional regulatory function. 
Thus, purification of Jhd2-containing protein complex from cells crosslinked with 
formaldehyde followed by MudPIT (Multidimensional Protein Identification Technology) 
(150) will be an important step to identify the Jhd2-interacting proteins and to further 
delineate the function of Jhd2. 
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Figure 33. Jhd2-LexA activates the (lexAop)8-LacZ reporter. Ten-fold serial dilutions of cells 
expressing JHD2-LexA were plated directly onto a nitrocellulose membrane. Expression of the 
reporter β-galactosidase was monitored by staining with X-gal, a colorimetric substrate. The 
strains harboring the (lexAop)8-LacZ reporter are indicated. 
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What is the Mechanism that Regulates the Subcellular Localization of Jhd2? 
The JmjN-JmjC interaction in Jhd2 is important for its normal subcellular 
localization (Fig. 19). Both the Jhd2(JmjNΔ) and Jhd2(K37E) mutants showed lower 
global and higher nuclear protein levels as compared to the WT Jhd2 (Figs. 15C and 19C). 
The higher nuclear levels of mutant Jhd2 might be due to an increased nuclear import rate, 
a reduced nuclear export rate, higher nuclear retention, a lower nuclear protein 
degradation rate, or a combination of these possible causes. Interestingly, Jhd2 contains 
two putative bipartite and one putative monopartite NLSs (Nuclear Localization Signals), 
and it also contains one putative leucine-rich NES (Nuclear Export Signal) (Fig. 34). It is 
possible that the interaction between the JmjN and JmjC domains in Jhd2 can modulate 
the presentation of its NLS/NES to the karyopherins to mediate the nuclear import/export 
of Jhd2. Therefore, to delineate the mechanism governing the subcellular localization of 
Jhd2 through its JmjN-JmjC interaction, it would be important to examine whether the 
putative NLSs/NES in Jhd2 indeed contribute to the regulation of its nuclear localization.  
As shown in the bottom panel of Fig. 34, the putative NES of Jhd2 overlaps with 
one of its putative NLSs. Intriguingly, an NES of the yeast actin-binding protein, Pan1, 
also overlaps with its third NLS (NLS3), and the nuclear export effect of this NES 
overwhelmed the nuclear import effect of NLS3 when they were fused to the NLS of 
histone H2B (151). However, inactivation of the Pan1 NES allowed the NLS3 to direct 
the fusion protein into the nucleus (151). Therefore, the overlapped NLS/NES in Jhd2 
might function as a “switch” in controlling its nuclear import/export. Therefore, testing 
these possibilities should provide important insights into the regulation of subcellular 
localization of Jhd2. 
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Figure 34. The putative NLSs and NES in Jhd2. Putative NLSs of Jhd2 are predicted by cNLS 
Mapper, an NLS-predicting algorithm based on the knowledge obtained from nuclear import 
assays in budding yeast (http://nls-mapper.iab.keio.ac.jp/) (152-153). A putative NES of Jhd2 
is predicted by NetNES, an NES-predicting algorithm based on the sequences of 67 identified 
NESs (http://www.cbs.dtu.dk/services/NetNES/) (154). Asterisks, denote the putative NLS 
and NES that overlap with each other as shown in the bottom panel. 
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How is the JmjN-JmjC Inter-domain Interaction in Jhd2 Regulated? 
The K37 residue in the JmjN domain of Jhd2 is critical for its JmjN-JmjC interaction 
(Figs. 19 and 21). I have tested the possibility that acetylation may occur on the Jhd2 K37 
residue and disrupt the inter-domain interaction in Jhd2. However, I was unable to detect 
any Jhd2 K37 acetylation by mass-spectrometry or Western blotting. It is possible that the 
Jhd2 K37 residue is modified only under certain cellular condition(s). Interestingly, MMS 
(methyl methanesulfonate) treatment decreased the global protein levels of Jhd2, but 
increased its nuclear protein levels in a concentration-dependent manner (Fig. 35A), 
which is very similar to the effects caused by disrupting the JmjN-JmjC interaction in 
Jhd2. Since MMS is an alkylating agent that causes oxidative stress, this result suggests 
that the K37 residue in Jhd2 may be modified to disrupt this inter-domain interaction in 
response to the alkylation-induced stress. Consistent with this hypothesis, overexpression 
of JHD2 led to slightly increased sensitivity to MMS (Fig. 35B, top panel), and the cells 
lacking Jhd2 exhibited a subtle enhancement in the resistance to MMS (Fig. 35B, bottom 
panel), implying that reducing the global levels of Jhd2 may promote cell survival under 
MMS-induced stress. Therefore, the identification of the modification(s) occurring on 
Jhd2 in response to MMS treatment may be beneficial to understand the physiological 
role and regulation of the JmjN-JmjC interaction in Jhd2. 
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Figure 35. MMS treatment affects the global protein levels and subcellular localization of 
Jhd2. (A) Western blot analysis of the Jhd2 levels in the WCEs and nuclear extracts obtained 
from cells treated with the indicated concentrations of MMS. (B) Analysis of the 
JHD2-overexpressed or -deleted cells for MMS sensitivity. Top panel, ten-fold serial dilutions of 
cells overexpressing JHD2 or jhd2(H427A) were plated onto medium with or without 0.01% 
MMS. Bottom panel, ten-fold serial dilutions of jhd2Δ cells with or without JHD2-9Myc 
expressing from a low-copy plasmid were plated onto medium with or without 0.02% MMS. 
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What is the Role of H2A in the Trans-histone Regulation of H3K4 Methylation? 
In addition to H2B, H2A also plays a role in the trans-histone regulation of H3K4 
methylation. An N-terminal patch (amino acids 16-20) in H2A is critical for high levels 
of H3K4me3 by modulating the levels of H2B K123 mono-ubiquitination (H2Bub1) 
(148). H2Bub1 is catalyzed by the E2 conjugating enzyme Rad6 and the E3 ligase Bre1 
(155-156), and this histone mark is removed by the ubiquitin proteases Ubp8 and Ubp10 
(157-158). Given the close proximity in the nucleosome between the H2A N-terminal 
patch and the H2B K123 residue (Fig. 36), it was proposed that this H2A patch may 
promote H2Bub1 by Rad6/Bre1 and thereby, contribute to the establishment of H3K4me3 
(148). In addition, my study has demonstrated that the H2A F26 residue is important for 
the Jhd2-chromatin association (Fig. 31). Interestingly, the F26 residue of H2A is also 
located close to the H2B K123 residue in the nucleosome (Fig. 36). Since ubiquitination 
is a bulky modification (7 kD), it is conceivable that H2Bub1 may hinder the binding of 
Jhd2 to its docking site (including F26) on H2A. Therefore, these findings raise a 
possibility that H2Bub1 together with the N-terminal region of H2A may play roles in 
regulating both the establishment and the removal of H3K4 methylation. Future 
examination of this hypothesis by ChIP analysis of the chromatin occupancy of Jhd2 in 
rad6Δ cells (lacking H2Bub1) and ubp8Δ/ubp10Δ cells (containing high levels of 
H2Bub1) will provide important mechanistic information for the trans-histone regulation 
of H3K4 methylation. 
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Figure 36. The H2A F26 residue is in close proximity to the H2B K123 residue. Crystal 
structure of the H2A (yellow)-H2B (pink) dimer in a yeast nucleosome is shown (PDB # 1ID3). 
The H2B K123 residue (red) is in close proximity to both the N-terminal patch (amino acids 
16-20, blue) and the F26 residue (green) of H2A. 
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